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Nutritional Factors and the Risk of Non-Hodgkin Lymphoma among 
Palestinians 
Prepared by: Maram Mohammed Al-Fityani / Dahdoul 
 
Supervisor: Dr. Rania Abu Seir 
 
Abstract: 
Background: The incidence of Non-Hodgkin Lymphoma (NHL) increased worldwide 
during the second half of the last century and then stabilized during the nineties but 
subsequently increased. Environmental factors and dietary habits have been reported to 
play an important role in the etiology of NHL by influencing the immune system. 
However, no such data are available from Palestine.  
Objectives: To participate in establishing a platform to study B-NHL in Palestine and 
further to examine the association between dietary factors and the risk of B-NHL among 
Palestinian B-NHL patients versus controls. 
Design: Case-control study. 
Methods: A case-control study was conducted between 2009-2013 including 306-
histological confirmed B-NHL cases and 392 cancer-free controls among adult Palestinians 
recruited from three major Palestinian hospitals in the West Bank and Jerusalem which 
have an oncology department in addition to Hadassah Hospital in West Jerusalem. In the 
primary study analysis, an imbalance was encountered in the regional distribution of cases 
and controls in the central area. In order to correct for this imbalance, I recruited 71 
controls from the primary health care centers in Jericho, Ramallah and Al-Azaria on the 
basis of frequency matched case-control study in terms of age and gender and region. The 
study participants were administered a questionnaire which is based on the international 
Epi-Lymph questionnaire, which focuses on demographic characteristics, types of 
environmental exposure and on diet and nutritional intake, specifically meat, milk, dairy, 
vegetables and fruits. Blood samples were also collected from participants for the purpose 
of DNA purification and viral serology testing. 
The overall data-base was used to study the association between nutritional factors and the 
risk of NHL. The data was analyzed by Statistical Package for the Social 
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Sciences(SPSS)and associations were examined by multivariate logistic regression. For 
food intake analysis, the median value for each food group was calculated from overall 
distribution of the study population in order to use the value below the median as a 
reference value to detect associations by logistic regression. 
Results: High consumption of meat (OR=1.8; 95% CI: 0.8-4.3) and milk (OR=1.3; 95% 
CI: 0.7-2.6) was found to be positively associated with the risk of B-NHL. Vegetable 
intake was also positively associated with the risk of B-NHL (OR=1.3; 95% CI: 0.4-4). 
Similarly, dairy products were significantly associated with an increased risk of B-NHL 
(OR=2.3; 95% CI: 1.2-4.4). In contrast, a significantly inverse association was encountered 
between fish consumption and B-NHL risk (OR=0.4; 95% CI: 0.2-0.8), and an inverse 
association was found between the consumption of fruits and B-NHL risk (OR=0.7; 95% 
CI: 0.2-2.1).  
Conclusion:The results of this study showed that dietary intake may affect the risk of NHL 
as positive associations were found with meat, milk, dairy products and vegetables 
consumption, while an inverse association with fish and fruits consumption was 
encountered. 
 
Keywords:  dietary factors, non-Hodgkin lymphoma, case–control study, Palestine.
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Chapter One 
______________________________________________________________ 
Introduction 
 
1.1 Background 
 
Non-Hodgkin lymphoma (NHL) is a heterogeneous group of malignant neoplasms that 
result from the malignant transformation of lymphocytes at different developmental stages 
in the lymph nodes, spleen, and other organs of the immune system in the body (Alexander 
et al., 2007). NHL  has more than 36 multiple subtypes that could arise from either B, T or   
natural killer cells according to new WHO classification (Jaffe, 2009) with specific 
molecular and clinical characteristics for each subtype (Novikova, Zotova, Dudareva, & 
DudarevAv, 1987). The major B-NHL subtypes are diffuse large B-cell lymphoma 
(DLBCL), follicular lymphoma (FL), Burkitt lymphoma and marginal zone B-cell (MZL) 
(Han et al., 2010; Schwartzkopff & Pahlitzsch, 1986). 
 
NHL has generated increased interest internationally; incidence rates of NHL worldwide 
increased during the second half of the last century, stabilized during the nineties, and 
increased subsequently after 2000 but at lower rate (Cartwright et al., 1999; Chiu & 
Weisenburger, 2003; Kabat et al., 2012; Muller, Ihorst, Mertelsmann, & Engelhardt, 2005; 
Zheng et al., 2004). Nowadays, the incidence of NHL is among the highest in the west; for 
example, in the USA, 71,850 people are expected to be diagnosed with NHL and 19,790 
are expected to die from this cancer (seer.cancer.gov/, 2014; Siddiqi & Rosen, 2015). 
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Furthermore, incidence rates have increased in Israel and some Arab countries, and 
according to the Middle East Cancer Consortium (MECC), in the period 1996-2001 the 
incidence rates of NHL per 100,000 were as the following: 15.2 for Israeli Jews, 14.2 for 
Egyptians, 10.2 for Israeli Arabs, 10.2 in Cyprus and 6.4 in Jordan (NCI, 2006). 
 
In Palestine, cancer was the second-leading cause of death after cardio vascular diseases 
with increased incidence rate that reached 79.5 cases per 100,000 population in 2013. The 
four most common types of cancer were: breast, colon, lung cancer and leukemia, yet, 
NHL was reported to be one of the most commonly diagnosed hematological 
malignancies, the 8
th 
most common cancer among women and the 11
th
 among men with an 
incidence rate of 2.2 per 100,000 population in 2013. In addition, mortality from Cancer in 
the West Bank gradually increased from 10.3%  of  all deaths in 2007  to reach 13.3 % in 
2013 (MOH, 2013). 
 
Young males are diagnosed more frequently with NHL than young females, but this 
difference decreases with age. In addition, NHL is more common among people over 65 
years and among whites than blacks (Chiu & Weisenburger, 2003; Czene, Adami, & 
Chang, 2007). 
 
Several risk factors have been reported to be associated with NHL including 
immunodysregulation (congenital immunodeficiency, acquired immunodeficiency, and 
autoimmune diseases), genetic risk factors, environmental exposures (e.g. infection and 
occupational exposures) in addition to personal habits and lifestyle which includes dietary 
intake (Mozaheb, Aledavood, & Farzad, 2012). The role of dietary factors in the etiology 
of NHL is still largely undefined despite the fact that food is the largest single antigenic 
challenge to the human immune system. It is quite likely that dietary habits and lifestyle 
play a role in the etiology of NHL by influencing the immune system regulation, oxidative 
stress and hormonal pathways regulating the proliferation of lymphoid tissue (Ali, Al-
Belushi, Waly, Al-Moundhri, & Burney, 2013; Mozaheb et al., 2012). 
 
Several previous studies have reported evidence of an association between dietary patterns 
and the risk of several types of cancers (Davis, 1992; Donaldson, 2004). Some studies have 
reported a positive association between the intake of protein, meat, dairy products and fat 
and  the risk of NHL, but some others have reported no association (Ali et al., 2013; Daniel 
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et al., 2012). In contrast, other studies have reported reduced risk of NHL with intake of 
fruits and vegetables (Kelemen et al., 2006; Ollberding et al., 2014; Thompson et al., 
2010). 
 
1.2 Study Problem      
 
NHL is a group of blood cancers whose incidence rates worldwide has risen much over the 
past decades (Kabat et al., 2012; Muller et al., 2005). In fact, NHL is the 8
th
 most common 
cancer among women and the 11
th
among men in Palestine (MOH, 2013). 
 
The increase in the incidence of NHL has been attributed to immunodeficiency, various 
infections, familial aggregation, blood transfusion, genetic susceptibility, occupational and 
chemical exposure, as well as dietary and lifestyle factors (Hartge et al., 2006). 
 
Dietary intake and nutritional factors have been reported to contribute to the risk of NHL 
(Ali et al., 2013). This association may be investigated by studying the dietary profile of B-
NHL patients before their sickness as compared to the cancer-free controls. 
 
1.3 Study Justification  
 
 NHL is an important cause of morbidity and mortality worldwide. NHL incidence rates 
from 1950-2000 increased globally, tripling in people aged >65years (Chiu & 
Weisenburger, 2003; Kabat et al., 2012). 
 In Palestine, cancer is considered to be the second leading cause of death, while NHL 
is currently reported to be one of the commonly diagnosed hematological 
malignancies, and ranks as the 8
th
 and the 11
th
 cancer in females and males 
respectively (MOH, 2013). 
 There are very limited studies in Arab and neighboring countries that investigated the 
association between NHL and nutritional intake, for example Omani study in 2013 (Ali 
et al., 2013). In Palestine, the association between NHL and nutritional intake has never 
been investigated. 
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1.4 Study Goal and Specific Objectives 
 
The study aimed to determine whether nutritional and dietary intake is associated with the risk 
of NHL among adult Palestinian B-NHL patients. And the specific objectives were: 
 
1) Participating in establishing a platform for studying lymphomas in Palestine. 
2) Studying the association between the B-NHL disease and the intake of some local 
food stuff like: 
a. animal protein intake 
b. milk and dairy intake 
c. vegetable intake 
d. fruit intake 
3) Examining the characteristics of B-NHL among Palestinian patients in terms of 
average age at diagnosis, gender distribution and histological subtype frequencies.  
 
1.5 Study Question 
 
Does dietary intake contribute to the risk of NHL? 
 
1.6 Study Hypothesis 
 
This study assumed that there is no association between food intake pattern and the risk of 
NHL disease. 
 
1.7 Ethical Considerations 
 
 This study was approved by the Research Review Committee at Al-Quds University. The 
questionnaire and the consent forms were both approved locally by the Research Review 
Committee at Al-Quds University and internationally by the Inter-Lymph Consortium.  
 
An approval letter by the Ministry of Health addressed to the health directorates was 
secured to facilitate data and blood samples collection (Appendix 1.1). 
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The objectives of the study, the consent form (Appendix1.2) and the interview and blood 
collection procedures were all clearly explained to the selected patients and controls in a 
special meeting. The subjects’ right to participate in the study or to withdraw from it at any 
point of time was emphasized; the researcher stated to the patients quite clearly that their 
decision whether to participate or not will have no effect on the level of medical care they 
receive. In addition, the researcher emphasized the confidentiality of the data to be 
collected. 
 
Finally, this thesis has not been submitted for a higher degree to any other university or 
institution, results of my own research work that used for scientific research purposes only. 
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Chapter Two 
______________________________________________________________ 
Literature Review  
 
2.1 Disease Pathogenesis 
 
The understanding of the molecular pathogenesis of NHL has significantly improved in 
recent years (Czene et al., 2007). NHL is a heterogeneous group of malignant neoplasms 
rising from the B, T and NK cells of the immune system. B-cell lymphomas (B-NHL) arise 
during the different stages of B-lymphocyte development, during which DNA 
modifications occur, and these modifications might drive to genetic abnormalities leading 
to lymphoma progress (Czene et al., 2007; Nogai, Dörken, & Lenz, 2011). 
 
B-NHL is the most common type of NHL and accounts for 80-85% of all lymphomas. 
Furthermore, the relative proportion of B-cell lymphoma has risen drastically over the 
years, from 53% in 1990 to 83% in 2012. The most common subtypes of B-NHL are: 
DLBCL, which accounts for 30–40%, FL, which accounts for 20–30%, Burkitt lymphoma, 
and marginal zone B-cell lymphoma (Cocco et al., 2013; Rodriguez-Abreu, Bordoni, & 
Zucca, 2007). Some types of NHL are considered to be aggressive (i.e. fast-growing), 
example: DLBCL and BL, and others are considered indolent (i.e. slow-growing) 
lymphoma, example: FL (Muller et al., 2005; Nogai et al., 2011). 
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2.2 Epidemiology of NHL 
 
The incidence of NHL has greatly increased during the last several decades by 80% 
between 1970s and 1990s. During the 1990s, the incidence of NHL stabilized and  even 
began to decrease between 1996-2000, this decrease was in part   attributed to a decrease in 
the incidence of AIDS, and since 2000 the incidence of the disease has been subsequently 
increasing but at lower rates than before (Alexander et al., 2007; Chiu & Weisenburger, 
2003; Sundewall, Lefvert, & Olsson, 1985). The epidemic of NHL has received 
considerable attention in many countries by various institutes and agencies  such as the 
United States National Cancer Institute (Chen, Lv, Pang, & Liu, 2013). Figure (2.1) shows 
the trend of NHL incidence over the last 50 years in the UK  among both genders and  is 
consdered representative of the global NHL trends. 
 
 
 
Figure (2.1): European age-standardized incidence rates of NHL, UK, 1975-2011 
(http://www.cancerresearchuk.org/, 2014). 
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Globally, NHL is the 8
th
 most commonly diagnosed cancer in men and the 11
th
 in women. 
North America, Europe, Oceania have the highest incidence of NHL in the world. in 
addition to several African countries (Boffetta, 2011). 
 
In the United States, NHL is the 6
th
 most commonly diagnosed cancer in both men and 
women. In 2015, it is estimated that there will be 71,850 new cases of NHL and 19,790 
NHL deaths with an incidence rate of 19.7 per 100,000 popul1ation 
(http://www.cancerresearchuk.org/, 2014; seer.cancer.gov/, 2014; Siddiqi & Rosen, 2015). 
The morbidity rate for NHL has risen by 27% in the last two decades among Jewish men 
and by 49% among Arab women. , in contrast, there was a moderate decrease trend among 
Jewish women and Arab men. In addition, Israel’s morbidity rates of NHL are among the 
top 20 countries in the world, and ranks second in mortality rates (http://en.cancer.org.il/, 
2015). 
 
In the Gulf Cooperation Council (GCC) which includes Bahrain, Kuwait, Oman, 
Qatar, Saudi Arabia and the United Arab Emirates, NHL is the 3
rd
 most common cancer 
(Ali et al., 2013), while in Egypt, NHL is the second most common cancer in adults and 
the incidence rates of lymphoma are among the highest in the world (Herzog et al., 2012). 
 
In Palestine, cancer incidence rate was 79.5per100,000 population and  the second leading 
cause of death after heart diseases causing 13.3 % from all deaths in 2013.NHL was 
reported to be the  8th  most common cancer among women and the  11th among men  
with an incidence rate of 2.2 per 100,000 population (MOH, 2013). 
 
Furthermore, the risk of NHL is strongly related to aging in both sexes. Figure (2.2) shows 
that age-specific incidence rates in UK rise slowly until the age of 50 years, then increases 
steeply over the age of 50 forming a peak in the 80-84 age group for both men and women. 
In addition, the figure shows that incidence rates are higher among men in all age groups 
(Alexander et al., 2007; Muller et al., 2005). 
 
Regarding NHL subtypes, DLBCL was reported to be the most common subtype 
worldwide and in the western countries followed by FL (Moinuddin, Dean, Vander Zwaag, 
& Dragutsky, 1987). In addition, a high incidence of FL and DLBCL was reported in 
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North America and Europe compared to a higher proportion of T-cell lymphoma in 
Asia(Boffetta, 2011). 
 
 
 
Figure (2.2): Average number of new case per year and age-specific incidence rates of 
NHL, UK, 2009-2011. (http://www.cancerresearchuk.org/, 2014) 
 
Historically, NHL has been about 40% higher in urban than in rural areas, such trends can 
be attributed to the diminishing socioeconomic differences(Muller et al., 2005). Moreover, 
developed countries have higher incidence rates of NHL compared to developing countries 
(Laurini et al., 2012). 
 
Reports have indicated a high incidence of DLBCL among Arabs, Turkish and Iranian, of 
FL among Kuwaiti Arabs(Ameen, Sajnani, Albassami, & Refaat, 2010), and of FL and 
small lymphocytic lymphoma (SLL) among Saudi Arabian patients(Akhtar et al., 2009). 
 
Nodal lymphoma occurs when lymphoma cells develop in primary lymphoid organs, but 
sometimes lymphoma cells begin in other parts of the body like the stomach and skin and 
these types are called extra nodal lymphomas. Gastrointestinal localizations represent the 
most common form of extra nodal lymphoma, followed by the central nervous system and 
the skin(AlShemmari, Ameen, & Sajnani, 2008; Mead, 1997). 
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Over the past 20 years, and as a result of the AIDS epidemic and other predisposing 
factors, the rate of occurrence of extra-nodal disease has increased more rapidly than nodal 
disease(AlShemmari et al., 2008; Zucca & Cavalli, 2000). Differences in the incidence of 
extra-nodal lymphomas vary between countries: in the USA 24% of NHL cases are extra-
nodal; while in Canada 27% are, in Israel 36%, in Denmark 37%, in Italy 48%, and in 
Hong Kong 29%. Little information is available about the actual incidence of extra nodal 
forms in developing countries(Newton, Ferlay, Beral, & Devesa, 1997), but Extra-nodal 
NHL was found common among patients of Arabic descent with DLBCL being the most 
common histological subtype(AlShemmari et al., 2008; Zucca & Cavalli, 2000) and in 
Lebanon it constituted 44% of cases (Newton et al., 1997), while in Kuwait 54%(Ameen et 
al., 2010). 
 
2.3 Etiological Risk Factors of NHL 
 
Several etiological risk factors have been reported to contribute in the increasing incidence 
of NHL worldwide. These risk factors are: immunodysregulation, genetic risk factors, 
infection with some viruses and bacteria, certain environmental and occupational 
exposures and lifestyle and dietary factors(Hartge et al., 2006). 
 
2.3.1 Immunodysregulation: 
 
Immunodysregulation is the strongest reported risk factor of NHL. It refers to a 
malfunction of immune system in the body, due to dysregulation of cytokines, which play 
an essential role in immune cell development and immune functions(O’Shea, Ma, & 
Lipsky, 2002). 
 
2.3.1.1 Congenital immunodeficiency 
Congenital immune deficiencies constitute a heterogeneous group of disorders with a 
variable degree of deficiency in B cell and/or T cell function. Examples of these 
syndromes include Weskit–Aldrich, ataxia telangiectasia. About 25% of patients with 
congenital immunodeficiency develop tumors during their lifetime, and 50% of these 
patients have NHL. These patients seem unable to promptly eliminate respiratory and 
gastrointestinal pathogens and are susceptible to chronic antigen stimulation(Grulich, 
Vajdic, & Cozen, 2007). 
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2.3.1.2 Acquired immune deficiency: 
 
2.3.1.2.1 Human immunodeficiency virus (HIV)  
Infection with HIV weakens the immune system and reduces the body's ability to fight 
infections which may lead to certain cancer like NHL(Epeldegui, Vendrame, & Martinez-
Maza, 2010). People with HIV infection were found to  be at an eleven-folds increased  
risk of NHL  compared to the general population, but the risk differ with different subtypes 
of NHL; the major AIDS associated NHL subtypes are: DLBCL, Burkitt lymphoma and 
primary lymphomas that arise in the central nervous system (Grulich et al., 2007; 
Vendrame et al., 2014). 
 
2.3.1.2.2 Iatrogenic immune deficiency (immunosuppressive drugs) 
Recipients of organ transplants receive a range of immune-suppressive pharmaceutical 
drugs. After transplantation, the relative risk of NHL was found to increase ten to fifty 
folds. This risk is closely correlated with the degree of immune suppressive e therapy and 
the organ transplanted. The risk of NHL is the highest during the first year after transplant 
when iatrogenic immune suppression is most intense, and patients of heart or lung 
transplantation have 4% higher incidence rate of NHL than other  organ  transplant patients 
(Grulich et al., 2007). 
 
2.3.1.3 Autoimmune diseases 
These include a heterogeneous group of conditions associated with a failure of the immune 
system to recognize self and consequent inflammatory diseases. The overactive immune 
system in patients of autoimmune diseases may lead to abnormal growth and division of 
lymphocytes; this might increase the risk of developing lymphomas. Many of the 
epidemiological studies that examined this association found increased risk among patients 
with rheumatoid arthritis, systemic lupus erythematous, celiac spruce (Grulich et al., 2007; 
Muller et al., 2005). 
 
2.3.2 Genetic Predisposition: 
 
 2.3.2.1Family history 
Studies have reported two to three-folds increase in the risk of NHL  and other 
hematological malignancies among first degree relatives (parent, sibling or child)  of NHL 
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(Chatterjee et al., 2004; Crump, Sundquist, Sieh, Winkleby, & Sundquist, 2012; Paltiel et 
al., 2000; Wang et al., 2007). 
 
2.3.2.2 Genetic variations or single nucleotide polymorphisms (SNPs) 
Several genetic variations or SNPs in different genes and pathways have been reported to 
modulate the risk of NHL. SNPs in pro-inflammatory cytokine genes that are involved in 
the regulation of immune defense mechanisms increase the risk of NHL, for example; 
SNPs in tumor necrosis factor (TNF) and interleukin (IL) genes(Chatterjee et al., 2004; 
Rothman et al., 2006). Further, SNPs in immunity genes influence lymphoma risk. The 
HLA region located on chromosome 6 has approximately 220 genes; Diepstra and 
colleagues (2005) have reported the association of these genes with lymphoid 
malignancies(Diepstra et al., 2005).  Additionally, several epidemiologic studies in the 
United States, Germany and Australia have reported an increased risk of NHL associated 
with genetic variations in the TLR10-TLR1-TLR6 region, TLR2 and TLR4 and TRAF1, 
RIPK3, BAT2,  MAP3K5, DUSP2, CREB1, B3GNT3, SELPLG, LSP1, FGG and 
ITGB3(Edlefsen et al., 2014; Skibola, Curry, & Nieters, 2007). 
 
Also, SNPs in genes involved in DNA double-strand break and repair, for example; 
mutated ATM and WRN genes that plays a crucial role in DNA double strand break repair 
and in other repair pathways and genes of GPX1, NOS2A, SOD2, AKR1A1, and 
CYBA2819165 and involved in ataxia telangiectasia(Skibola et al., 2007). 
 
2.3.3 Environmental Exposures: 
 
Only 5–10% of all cancer cases can be attributed to genetic factors and the remaining   are 
mainly attributed to environmental and lifestyle factors(Diver, Teras, Gaudet, & Gapstur, 
2014; Douse, Powell, Milsom, & Mitchell, 1989). 
 
2.3.3.1Infectious exposures: 
 
According to the American cancer society, some infections may raise the risk of NHL 
through different mechanisms; for example, some viruses can directly affect the DNA of 
lymphocytes helping to be transformed into cancer cells by directly affecting their DNA, 
like HTLV-1, EBV, while other viruses act through weakening the immune system, like 
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HIV.  A third mechanism is that the infections may cause chronic immune stimulation like 
Helicobacter pylori (H.Pylori) and Chlamydia psitta(Peveling-Oberhag, Arcaini, 
Hansmann, & Zeuzem, 2013; Shawki, Meshaal, El Dash, Zayed, & Hanna, 2014). 
 
2.3.3.1.1 Human herpes virus 4 (EBV) 
Herpes virus is highly prevalent worldwide. Infection with EBV is associated with a wider 
spectrum of NHL subtypes in the context of immunosuppressant resulting in the 
proliferation of transformed B-cells normally controlled by T-cell-mediated immunity. 
About half of DLBCL cases infected with HIV  are EBV positive, whereas about 30% of 
Burkitt lymphoma cases are EBV associated, and nearly all cases (>95%) of endemic 
Burkitt lymphoma in Northern Africa are EBV positive (Muller et al., 2005). EBV has also 
been linked with developing nasal-type extra-nodal natural killer/ T-cell lymphoma, 
lymphomatoid granulomatosis (a form of B-cell lymphoma), and post-transplant lymph 
proliferative disorder(Teras et al., 2015). 
 
2.3.3.1.2 Hepatitis C virus (HCV) and Hepatitis B virus (HBV) 
Several epidemiological studies have demonstrated an increased NHL risk with chronic 
HBV or HCV infection, with potential specificity for particular NHL subtypes. B-NHL 
subtypes most frequently associated with HCV are marginal zone lymphoma and DLBCL 
(Engels, Cho, & Jee, 2010). The most important evidence for association between HCV 
infection and lymphoma development is the observation of B-NHL regression after HCV 
eradication by antiviral therapy(Peveling-Oberhag et al., 2013). 
 
2.3.3.1.3 Helicobacter pylori 
H.pylori is a causative agent for some types of gastric lymphomas like mucosa-associated 
lymphoid tissue (MALT), which is an indolent tumor arising from B cells and affecting the 
gastric mucosa (gastric NHLs). Some studies reported a certain proportion of patients who 
are H.pylori-positive with histological evidence of MALT lymphoma and gastric DLBCL 
this might be due to chronic inflammation that results in the colonization and proliferation 
of lymphocytes in the gastric mucosa(Suzuki et al., 2006). 
 
2.3.3.1.4 Other infectious agents 
Infection with Chlamydia psittaci, which can infect humans via contact with animal feces 
and contact with birds, and the vector borne agent Borrelia burgdorferi, have been 
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associated with rare MALT lymphomas (Muller et al., 2005).  In addition, human T-cell 
lymphotropic virus- type I (HTLV-I) is an established cause of adult T-cell 
leukemia/lymphoma. There are also some bacterial infections involved in the etiology of 
NHL such as Plasmodium falciparum, and Borrelia afzelii(Engels et al., 2010). 
 
 2.3.3.2Occupational exposures 
The association between NHL risk and different occupations has been reported by several 
epidemiological studies (Alavanja et al., 2014).The evidence points that the elevated risk 
of NHL among farmers and agricultural workers is due to the exposure to pesticides and 
other agricultural chemicals such as solvents, fuels, oils, dusts, which are either potentially 
carcinogenic or lead to chronic antigenic stimulation . 
 
A number of other jobs and industries, including fishing, construction, paper, wood and 
leather industries, metal workers, painters, electrical engineers, teachers and health care 
workers, have also been suggested to entail an increased risk of NHL (Alavanja et al., 
2014; Boffetta & de Vocht, 2007; Schinasi & Leon, 2014). 
 
 2.3.3.3Personal habits and lifestyle: 
 
Lifestyle, personal habits and diet factors have been reported to play an important role in 
the etiology of NHL(Ali et al., 2013). 
 
2.3.3.3.1 Smoking, alcohol consumption and hair dyes 
Smoking reported in many studies to have no association with NHL, but was found to be 
associated with 30% increased risk of FL(Morton, Hartge, et al., 2005). On the other hand, 
some studies that examined the association between alcohol consumption and NHL risk 
have suggested that consumption of alcohol may be protective from NHL. In addition, the 
risk of NHL was reported to be associated with the use of hair dyes and hair coloring 
products in many studies, and the risk varied by the type of dye products, period of use, 
duration and intensity of use(Diver et al., 2014). 
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2.3.3.3.2 Dietary intake:  
 
Several epidemiological studies examined the possible association between dietary intake 
and the risk of NHL, but results were inconsistent. The suggested mechanism of action for 
dietary factors include both enhancement and suppression of the immune system in the 
body; therefore they may increase the risk of NHL or protect against it for example, the 
suppressive role might be due to the effect of fat and animal proteins(Ali et al., 2013; 
Purdue et al., 2004; Skibola, 2007), while the protective role might be due to the 
antioxidant properties of vegetables and fruits that protect against the effects of free 
radicals(Thompson et al., 2010; Zheng et al., 2004).  The role of dietary factors and the 
risk of NHL were found to vary also by NHL subtype. 
 
• Saturated fat and animal protein 
In the past, the epidemiological studies that assessed the association between dietary intake 
and the risk of NHL were very limited. Davis and his colleagues reported a significant 
increase in the risk of NHL and high consumption of liver and oil in addition to a moderate 
increase in consumption of meats, salami, sausages and margarine (Davis, 1992). Later, 
several cohort and case-control studies reported an increased risk of NHL associated with a 
higher consumption of animal protein, saturated fat and higher intakes of retinol, eggs, and 
dairy products. These studies, however, showed a reduced risk for polyunsaturated 
fat(Chiu et al., 2008; Zhang et al., 1999; Zheng et al., 2004). In addition, the first Omani 
study showed that meat intake is associated with increased risk of NHL(Ali et al., 2013). 
Moreover, Mozaheb and colleagues found that diets high in trans fatty acids (TFAs), high-
fat dairy products and most types of meat  were positively associated with the risk of NHL, 
while diets high in omega3- fatty acid found in plant oils, fresh fish and total seafood were 
inversely associated with risk of NHL(Mozaheb et al., 2012). 
 
In a case-control study, conducted by Charbonneau and his colleagues and included 603 
cases and 1,007 controls, diet was assessed with a 128-item food-frequency questionnaire. 
The findings showed that TFA intake was positively associated with NHL risk (OR=1.6;  
95% CI: 1.2- 2.2), while intake of omega-3 fatty acids was inversely associated with NHL 
risk (OR=0.5; 95% CI: 0.4- 0.7)(Charbonneau et al., 2013). In contrast, a large U.S. cohort 
study reported no association between intake of meat or other animal products and risk of 
NHL(Daniel et al., 2012). 
 16   
 
The increased risk of NHL associated with the consumption of meats and animal protein 
was attributed to the suppressive effect of the immune system in the body(Mallinger, 
Schmid, & Neu, 1987). The suppression might be due to the presence of chemicals such as 
haem, which is a red pigment that can irritate or damage the cells causing them to divide 
much more than normal to compensate for this damage and subsequently increase cancer 
risk(Cross, Pollock, & Bingham, 2003). Haem could also stimulate the bacteria in our guts 
to produce chemicals called N-nitroso compounds which are known to be carcinogens. In 
addition, cooking meat at high temperatures (by grilling or boiling) can produce harmful 
chemicals such as heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons 
(PAHs), which are also known to be carcinogenic(Layton et al., 1995). 
 
• Milk and dairy products 
Many epidemiological studies in the US, Italy, Norway and other countries, from 1983 to 
2007, reported a significant increase in risk of NHL associated with a high consumption of 
milk and dairy products like butter, margarine, cream soups, mayonnaise, mutton fat, ice 
cream or milkshakes, and cheese(Chiu et al., 2008; Davis, 1992). Other studies found milk 
consumption to be significantly associated with a higher risk of specific NHL subtypes 
such as DLBCL, but not associated to increased risk of other types like FL (Chiu et al., 
2008). In contrast, other studies did not find any association for the consumption of milk 
and dairy products and the risk of NHL(Ali et al., 2013; Mozaheb et al., 2012; Skibola, 
2007). 
 
• Fish 
Based on a number of case-control and prospective cohort studies, some evidence showed 
that fish intake may reduce risk for NHL(Ali et al., 2013; Fritschi, Ambrosini, Kliewer, 
Johnson, & Canadian Cancer Registries Epidemiologic Research, 2004). In contrast, other 
studies reported an increased risk for certain subtypes of NHL like FL with consumption of 
fish(Daniel et al., 2012; Yang et al., 2014). In consistence with a recent meta-analysis that 
included seven case-controls and two prospective cohort, some previous case-control 
studies   found no association between the consumption of fish and the risk of NHL(Chang 
et al., 2005; Yang et al., 2014). 
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• Fruits and vegetables  
Intake of fruits and vegetables is an important element of any healthy diet, and varies 
reflecting economic, cultural and agricultural environments among countries. It has been 
estimated that insufficient intake of fruit and vegetables could cause up to 14% of 
gastrointestinal cancer deaths(Stevens, 2009). Epidemiologic evidence suggests that intake 
of fruits and/or vegetables may play a role in the etiology of NHL. Several studies reported 
a reduced risk of NHL with higher intake of green vegetables, carrots and dietary fiber and 
for several fruit and vegetable items(Davis, 1992; Kelemen et al., 2006; Zheng et al., 
2004). Similarly, other studies that investigated the intake of different types of vegetables 
and fruits separately like cruciferous vegetables, green leafy vegetables, and red 
vegetables, and reported a reduced NHL risk(Han et al., 2010). Furthermore, a case-control 
study conducted in 2012 showed that most fresh fruits like citrus, apple, melon and water 
melon had a protective effect against NHL, but fruit products such as compote, natural 
juice and commercial juice were associated with an increased risk of lymphoma(Mallinger 
et al., 1987). Another case-control study conducted in Oman showed that there was a 
significantly reduced risk of NHL associated with higher consumption of vegetables 
(OR=0.2; 95% CI: 0.1-0.8), though no significant association with the risk of B-NHL was 
detected with the consumption of fruits(Ali et al., 2013). Additionally, a meta-analysis of 
case-control and cohort studies conducted between 1966 - 2012 focused on fruit and 
vegetable consumption and the risk of different histological subtypes of B-NHL reported 
that vegetables intake had significant inverse association with DLBCL and FL(Chen et al., 
2013). In contrast, other studies reported no association between vegetables, dark green 
vegetables, high-nitrate vegetables and risk of B-NHL (Chiu et al., 2008; Ollberding et al., 
2014). 
 
Vegetables and fruits rich in antioxidant nutrients were hypothesized to be protective 
against many types of cancer, including NHL, and several mechanisms have been 
suggested; one is through reduction of reactive oxygen species responsible for oxidative 
DNA damage, another is through the regulation of cell survival and apoptosis pathways, in 
addition to protection of immune responses. Additionally, it was hypothesized that 
alimentary fibers may affect the dilution, absorption, and/or breakdown of fat and animal 
protein in the gut, either directly or indirectly, by modifying the gut micro flora(Davis, 
1992; Zheng et al., 2004). 
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2.4 Nutritional status among Palestinians 
 
Many studies were conducted in Palestine during both the first and the second Entifada to 
assess the nutritional status. In addition, Palestine is one of the three Middle Eastern 
countries that have national nutrition surveillance systems that have been functional since 
2006(Friedman, 2014). A study was conducted in 2003 by Abdeen and his colleagues for 
nutritional assessment in the West Bank and Gaza Strip for the purpose of evaluating food 
security. The parameters included in the study were chronic and acute malnutrition and 
nutrient deficiencies for critical macro and micro nutrients in pre-school age children (ages 
13-59 months). The study reported that the prevalence of acute and chronic malnutrition 
were acceptable, yet the quality of food intake suffered from significant decline in daily 
intake of micro and macro nutrients compared to the defined recommended daily 
allowance, the nutrients assessed were energy and protein intake, vitamin A and E, folate, 
iron and zinc (Abdeen, Greenough, Chandran, & Qasrawi, 2007). 
 
In 1991, a community-based cross-sectional survey conducted by the Norwegian 
universities' committee for development research (NUFU) assessed food consumption 
patterns in the West Bank and reported a high proportion of dietary energy from fat and 
high consumption of most animal products among the wealthiest households (Stene et al., 
1999).   
 
In addition, a cross-sectional survey that assessed the prevalence and distribution of 
overweight and obesity and their associations among adults in Palestine andreported that 
obesity and overweight are public health problems in Palestine, withadults aged 45–54 
years old being more likely to be obese or overweight(Abdeen et al., 2012). Furthermore, a 
cross-sectional survey conducted in 2005 in Ramallah, Nablus and Hebron governorates 
reported that irregular meal patterns were common among Palestinian adolescents and a 
positive association between high standard of living index in Ramallah and increased 
intake of animal foods, western-style foods, dairy products, fruits and vegetables, sweets 
and salty snacks was found. Moreover, the study found that only 26.1 % of the students 
have three main meals daily, one quarter of the students drink milk daily, >70% consumes 
vegetables and >50% consumes fruits daily(Mikki, Abdul-Rahim, Shi, & Holmboe-
Ottesen, 2010). 
 
 19   
 
Another study conducted in East Jerusalem showed that 24.3% of adolescents were 
overweight and 9.9% were obese, while 4.8% were underweight, of which 23.3% were 
anemic. In addition, 55.7% of boys and 64.8% of girls had inadequate energy intake, 
15.1% of boys and 43.1% of girls reported inadequate protein intake and the majority of 
both boys and girls met <80% of the recommended daily allowances (RDA) for most 
micronutrients(Jildeh et al., 2011). The findings of these studies detected a need for 
effective interventions to change existing dietary habits with healthy ones. 
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Chapter Three 
______________________________________________________________ 
Study Framework  
 
3.1 Conceptual Framework  
 
The conceptual framework presents the relation between the dependent variable (NHL) 
and the independent variables (dietary factors) and (demographics and social 
characteristics).Figure (3.1) shows the association between the dependent variable (NHL) 
and the independent variables (dietary intake, personal history of cancer, family history of 
cancer and demographic factors) which may increase or decrease the risk of NHL. 
 
3.2 Study Variables 
 
In the present study, the dependent variable isB-NHL, which is defined as a blood cancer 
or a heterogeneous group of malignant neoplasms that result from the malignant 
transformation of lymphocytes at different developmental stages in the lymph nodes, 
spleen, and other organs of the immune system in the body and originates from B-
lymphocytes (Ansell & Armitage, 2005). The independent variables that may contribute to 
the risk of NHL and are included in the study are defined in Table (3.1). 
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Figure (3.1): Conceptual framework of the study. 
 
Table (3.1-a): Operational definition of study variables. 
 
Variable Operational Definition 
Age Age of participants at the time of interview measured in years 
Gender Gender of the participants categorized into male and female 
Education level 
Number of years  completed in school,  categorized into: 
 Partial primary (< 6th grade) 
 Primary school completed 
 Partial secondary 
 High school completed 
 Diploma 
 Bachelor degree 
 Graduate studies 
Region 
Region where the participants were recruited from: 
 North: Nablus, Jenin, Tubas, Qalqilya, Tulkarem, Salfit. 
 Middle: Ramallah, Jericho and Jerusalem. 
 South: Bethlehem, Hebron. 
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Table (3.1-b): Operational definition of study variables. 
 
Variable Operational Definition 
Marital status 
The social status of the participant at time of recruitment, categorized into: 
 Never married 
 Single 
 First marriage 
 Second marriage or more 
 Divorced or separated 
 Widowed 
Serving (USDA, 
2015) 
The portion size of food depending on the type of food served: 
 Fish: 30 g 
 Meat: 30 g 
 Milk: 240 ml 
 Dairy products: 240 ml 
 Vegetables: 240 g 
 Fruits: 120 g 
Meat intake 
Average number of servings of red meat and chicken consumed weekly over the 
last six months for controls and before the diagnosis of the disease for B-NHL 
cases 
Fish intake 
Average number of servings of fish consumed weekly over the last six months 
for controls and before the diagnosis of the disease for B-NHL cases 
Milk intake 
Average number of servings  of milk  consumed weekly over the last six months 
for controls and before the diagnosis of the  disease for B-NHL cases 
Dairy products 
intake 
Average number of servings  of dairy products consumed weekly over the last six 
months for controls and before the diagnosis of the disease B-NHL cases 
Vegetables intake 
Average number of servings  of vegetable consumed weekly over the last six 
months for controls and before the diagnosis of the disease B-NHL cases 
Fruits intake 
Average number of servings of fruit (120 g) consumed weekly during the last six 
months for controls and before the diagnosis of the disease B-NHL cases 
Personal history of 
cancer 
Having had a cancer in the past 
Family history of 
cancer 
Having a one or more first degree relatives (parent, sibling,, child) who had 
cancer 
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Chapter Four 
______________________________________________________________ 
Methodology  
 
This chapter describes the methodology of the large B-NHL project that this study was a 
part of. 
 
4.1 Study Design 
 
A large case-control study of B-NHL was conducted among adult Palestinians. the study 
involved  a questionnaire, serology and genetic analysis, which were used to study the 
different environmental and genetic determinants of B-NHL by comparing cases to 
controls. Participants were administered a standardized questionnaire-based interview  and  
20 ml peripheral blood was collected for the purpose of DNA purification for the genetic part 
of the study and serum separation to be used for viral serology analysis. Recruitment of 
human subjects in this study was approved by the Institutional Review Boards at the 
collaborating institutions. My contribution to the large case-control study was focused on 
recruiting controls (n=71). The whole database of the case control study was used to study 
the association between dietary intake and NHL risk. 
 24   
 
4.2 Study Setting  
 
Arab B-NHL cases were recruited in the West Bank from two major hospitals, these hospitals 
contain oncology departments and are supervised by the Palestinian Ministry of Health 
(National Hospital in Nablus and Al-Husein Hospital in Beit-Jala), in addition to Augusta 
Victoria Hospital, which is located in Jerusalem and supervised by Israeli Ministry of Health 
but all of their patients are referred from the West Bank. These are the major centers that 
provide treatment for hematological malignancies for Palestinians. Additionally, Arab cases 
treated both in Hadassah Hospital Ein-Kerem and Mount Scopus were also recruited in the 
study. Controls were recruited from MOH primary health care clinics or from the 
collaborating hospitals. 
 
4.3 Study Population 
 
Cases (n=306): Eligible cases were individuals aged ≥18years newly diagnosed with B-NHL 
within <18months of diagnosis. Patients were recruited through four major study centers: i) in 
the north (National Hospital in Nablus), ii) in the south (AL-Husein Hospital in Beit-Jala) and 
iii) in the middle (Augusta Victoria Hospital), iv) in addition to incident B-NHL patients 
being treated in Hematology Day Care Centers and Clinics in Hadassah–Hebrew University 
Medical Center both in Mount Scopus and Ein-Kerem were also recruited. The median time 
from diagnosis to recruitment for the different centers was between 1-11 months which 
diminishes the probability of a survival bias.   
 
Controls (n=392): Initially,  321 clinic-based cancer-free controls aged ≥18years were 
recruited through thirteen governmental medical centers related to the Palestinian Ministry of 
Health (MOH) and distributed all over the West Bank (Southern Hebron, Hebron, Bethlehem, 
Jericho, Ramallah, Northern Ramallah, Jenin, Qalqilya, Jerusalem, Nablus, the Old City of 
Nablus, Salfit and Tulkarim MOH medical centers). Some controls were recruited from the 
collaborating hospitals: National Hospital of Nablus, Augusta Victoria Hospital, Hadassah 
Medical Center and the blood bank donors of Al-Makassed Charitable Hospital. These 
controls were cancer-free individuals accompanying other cancer patients but not first or 
second degree relatives or blood donors in the case of Al-Makassed Hospital. Additional 71 
controls were recruited later for the purpose of correcting the regional distribution imbalance 
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that was found in the primary analysis, which was my contribution to the larger study. 
Controls were recruited from the MOH medical centers.  
 
Inclusion-exclusion criteria: Eligible cases were individuals ≥18 years old, with 
pathologically confirmed diagnoses of B-NHL within less than 18 months. Consequently, for 
each case, we referred to the patient’s oncologist or to the cancer registry file to fill out a 
pathology report (Appendix 4.1) to confirm the diagnosis. Any participant below the age of 
18 years or with unconfirmed diagnosis was excluded from the study. Controls were adult 
cancer-free individuals who were frequency matched to the patients in terms of age and 
gender. Any control that was related to any of the patients was excluded from the study. 
 
4.4 Study Tool 
 
The questionnaire that was used from the beginning of the large project was originally 
formulated in English based on the questionnaire of the EpiLymph (European multicenter 
case-control study which is part of the International Lymphoma Epidemiology Consortium-
InterLymph) (Appendix4.2). The questionnaire was translated into Arabic (Appendix 4.3) for 
the purpose of conducting interviews with the target groups. Forward and back translation 
was performed in order to assure reliability. Further, a pilot study was conducted to check the 
reliability and feasibility of the questionnaire in order to make the necessary amendments and 
corrections. The questionnaire was administered in hospitals, outpatient clinics and Ministry 
of Health clinics, in a face-to-face manner. The questionnaire contains six sections including 
more than 500 variables collecting detailed information on a number of potential NHL risk 
factors. The first section focuses on socio-demographic characteristics including age, gender, 
marital status, education level, and family size, birth order, and attendance of day care and 
further it focuses on family origin of the participant, and his father, mother, grandfather and 
grandmother. The second section explores occupational history and the related exposures. The 
third section gathers information about residence properties including address, type, floor, 
source of water, number of peoples residing in, number of rooms, location of bathroom, and 
duration of residency.  The fourth section investigates personal characteristics and habits 
(weight and height before and after illness, smoking, hair dye use, sun exposure and dietary 
intake). The fifth involves information about personal hobbies (physical activity, gardening, 
domestic use of pesticides and insecticides and hobbies that involve usage of chemicals). The 
sixth section focuses on medical history (history of specific infections, autoimmune diseases 
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or atopic conditions like asthma, eczema and hay fever, hospitalization for infection during 
infancy and during the life-time, vaccinations, antibiotic use, exposure to X-rays, contact with 
animals, medications, blood transfusion, history of cancer other than NHL, family history of 
cancer and autoimmune diseases.  
 
Dietary intake was assessed using food frequency questionnaire (FFQ) which is the most 
common dietary assessment tool used in large epidemiologic studies of diet and health For 
each food item, a commonly used portion size or unit (serving) was specified and the 
respondents were asked how often on average over the last months they had consumed that 
amount of each food item. There were 7 possible responses, ranging from ‘never to 1or 
more times daily. 
 
In this study, the same previously described questionnaire was used in interviewing the 
newly recruited controls; blood was also collected from them for other purposes in the 
study. The primary focus of this study was on the part of the questionnaire which is related 
to food frequency where daily consumption of routine food items including red meat, 
chicken, fish, milk and dairy, vegetables and fruits, also intake of beverages as water, tea, 
and coffee, to obtain information on the frequency and amount of food items consumed 
during the past. 
 
4.5 Data Collection 
 
After getting an approval for the continuation of the project the process of recruitment was 
started by explaining the study and its rational to the participants, and then they were 
consented. After that, the participants were administered the questionnaire in a face to face 
interview, blood was also collected from the participants and then transferred to the 
laboratory  where serum was separated  from plain blood, aliquoted and kept at -20
o
C, and 
also DNA was purified from EDTA blood. 
 
Cases: The diagnosing physicians or the research assistants introduced the research project 
to the patients and asked for their willingness to be contacted by an interviewer. In case of 
a positive response, an interviewer explained the project more comprehensively and 
handed out written information material including informed consent. When consent was 
given, the interviewers administered the questionnaires in the hospital in a face to face 
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interview that lasted for 45-60 minutes and obtained blood. In order to confirm the 
pathology diagnosis for each case, we referred to the patient’s oncologist to fill out a 
pathology report. This report specifies the subtype of lymphoma, age at diagnosis, place of 
diagnosis, cell markers by immune-staining or immune-histochemistry, site of biopsy, stage 
of disease, extra-nodal involvement,  presence of B-symptoms, lactate dehydrogenase level 
(LDH) and the prescribed treatment.  
 
Controls: They were approached by the interviewer and consented after getting the proper 
explanation about the project. All controls were administered the same questionnaire in a face 
to face interview within the hospital or the medical centers. The newly recruited 71 controls 
were from the middle regions and were distributed as the following: 23 from Jericho, 26 
from Al-Azaria (Jerusalem) and 22 from Ramallah. 
 
4.6 Validity 
 
The EpiLymph questionnaire has been externally validated and used in several 
internationally published studies since 2002. Despite that, some questions suffer from low 
validity like the antibiotics and vaccination questions which are highly affected by recall 
bias; therefore they were excluded from the analysis. 
 
4.7 Statistical Analysis 
 
Quantitative data that were collected from participants within the questionnaires were 
cleaned, coded, entered and analyzed using the Statistical Package for the Social Sciences, 
(SPSS version 21). Descriptive analysis of food intake was dependent on the median which 
was used to describe the sample’s intake of each food item, the use of the median provide 
more accurate measure to describe the subset of data given that the categories  used were 
unequally distributed and the data was not normally distributed. Furthermore, the values 
below the median were used as the reference group for all comparisons. 
 
Odds ratios (OR) and 95% confidence intervals (95% CI) were used as the measure of 
association between the independent variables and B-NHL. Unconditional logistic 
regression was used to estimate ORs and the corresponding 95% CI. In addition, a 
multivariate regression model that is adjusted for age in years and gender was constructed. 
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The sample size provided a power of >90% to detect an odds ratio of 2.2 with 15% 
reporting exposure among controls. The level of significance was calculated at alpha-level 
of 0.05. 
 
 
 
 
 
 
 29   
 
 
 
 
  
 
 
Chapter Five 
______________________________________________________________ 
Results 
 
This chapter presents the findings of the study including sociodemographic characteristics, 
disease characteristics and association between B-NHL and food intake. 
 
5.1 Socio-demographic Characteristics 
 
In the current study of B-NHL, a total of 306 B-NHL cases and 392 cancer-free controls 
were recruited. Confirmed B-NHL cases were diagnosed and recruited from different 
hospitals in Jerusalem and the West Bank as shown in Table (5.1); 28.3% of the cases were 
recruited from Augusta Victoria Hospital (Al-Mutalaa), 16.6% from the National Hospital, 
13.7% from Beit-Jala Hospital (Al-Husein), 22.5% from Hadassah Hospital and 17.3% 
from MOH primary health care clinics. Controls also were recruited from different 
hospitals in Jerusalem and the West Bank as shown in Table (5.1); 10.2% of them were 
from Augusta Victoria Hospital, 4.2% from National Hospital, 77% from MOH primary 
health care clinics and 8.6% from Al-Makassed Blood Bank Volunteers. 
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Table 5.1: Distribution of study subjects by recruitment center. 
 
Recruitment Center 
Cases Controls 
(n) % (n) % 
Augusta Victoria Hospital 87 28.3 32 10.2 
Hadassah Hospital 69 22.5 0 0 
Beit-Jala Hospital 38 12.4 0 0 
National Hospital 51 16.6 13 4.2 
MOH clinics 53 17.3 321 77 
Al-Makassed Blood Bank 0 0 27 8.6 
 
The mean, median and SD for age at diagnosis were 50.8, 52 and 16.6 years, respectively, 
indicating a young age at diagnosis. On the other hand, the mean, median and SD for age at 
recruitment were (52.9, 53 and 16.6 years respectively) confirming the recruitment of 
incident cases diagnosed within less than 18months. Figure (5.1) shows the distribution of 
cases by age at diagnosis; a high proportion of cases were in the younger age groups (18-
34 years), and as age increased, the number of cases increased, with a peak noticed in the 
age group 60-64 years. An almost threefold increase in the incidence of NHL with aging 
could be also noticed, which emphasizes the role of aging as an important risk factor in 
NHL.  
 
 
 
Figure 5.1: Distribution of B-NHL cases by age at diagnosis in the different age groups. 
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Table (5.2) demonstrates the demographic characteristics of B-NHL cases and controls 
including age, gender, regional distribution, educational level, marital status, birth order 
and recruitment centers. The controls were designed to be frequency matched with the 
patients in terms of mean age at recruitment, gender. 
 
The mean age of B-NHL cases at recruitment was 52.9 with a standard deviation (SD) of 
16.6 and for controls 51 years (SD=15years) for controls (Table 5.2). The distribution of 
both cases and controls was close in most age groups, but  higher proportion of controls 
were recruited in two age groups, 40-44years and 45-54 years, thus confirms the matching 
criterion and supply a window for the matching process. Consequently, and as a result of 
the imbalance, our multivariate models were adjusted for age. Figure (5.2) demonstrates 
the distribution of cases and controls in the different age groups. 
 
 
 
Figure (5.2): Age distribution of B-NHL cases and controls at the time of recruitment. 
 
Among the cases, the males and females were equally represented, with a percentage of 
(49.5%) and (50.5%) respectively, whereas higher proportion of controls were females, 
therefore the multivariate models were also adjusted for sex. The cases and controls were 
similar with respect to the marital status(Table 5.2). 
 
With respect to regional distribution of the participants; the regional distribution of cases was 
as the following: northern region contributed to 24.7% of B-NHL cases, followed by southern 
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region(31.9%) and then middle region(39.5%). On the other hand, the regional distribution of 
controls was as the following:19.9% were from the northern regions compared to 44.9% from 
the south and 32.9% from the middle regions (Table 5.2). 
 
In regard to education, an equal percentage among both the cases and controls were found 
to be illiterate, while a higher proportion of cases (34.9%) had primary education 
compared to controls (23%). In contrast, almost one fourth of the controls had a first 
university degree (26.1%) versus only one-sixth (15.6%) among the cases (Table 5.2). 
 
As for marital status, there was no difference between the cases and controls as most of 
them were currently or previously married.  In regard to birth order no major differences 
were found between cases and controls, most of participant from both were in the second 
or the third order in their families (Table 5.2). 
 
Table (5.2): Socio-demographic characteristics of B-NHL cases and controls including, 
age at recruitment, gender, region, educational level, marital status and birth order. 
 
Variable Category Cases Controls 
(n) % (n) % 
Age at recruitment Mean age (years ± SD) 52.9±16.6 51.4±15.1 
Gender Male 152 49.5 168 42.7 
Female 155 50.5 225 57.3 
Region North  75 24.7 78 19.9 
Middle 120 39.5 129 32.9 
South  97 31.9 176 44.9 
Others 12 3.9 9 2.3 
Education Illiterate 44 14.6 57 14.9 
Primary education 105 34.9 88 23 
Secondary education 92 30.6 131 34.2 
First university degree 47 15.6 100 26.1 
Others 13 4.3 7 1.8 
Marital status Never married 41 13.4 34 8.7 
Married or previously 
married 
264 86.6 359 91.3 
Birth order 1 71 23.4 68 17.8 
2 – 3 115 37.8 118 31 
4 – 5 60 19.7 100 26.2 
6 + 58 19.1 95 24.9 
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5.2 B-NHL Subtypes  
 
Table (5.3) presents the relative distribution of B-NHL cases by NHL subtypes.  diffuse 
large B-cell lymphoma (DLBCL) was the most common NHL subtypes  (70.7%), followed 
by follicular lymphoma (FL) ( (14%),  low grade lymphoma (4.2%), small lymphocytic 
lymphoma (SLL) (3.9%), mantle cell lymphoma (MCL) and mucosa-associated lymphoid 
tissue (MALT) each contributed to 1.3%, marginal zone lymphoma (MZL) (1%), and 
finally Burkitt and lymphoblastic lymphoma each contributedto (0.7%).  
 
Table (5.3): Distribution of B-NHL cases by subtype. 
 
 
 
 
 
 
5.3 Nutritional Intake  
 
The results of this study showed that the median value of weekly consumption of both 
cases and controls for each food group was below the dietary reference intake (DRI). Table 
(5.4) shows the distribution of all food categories for both cases and controls, the median 
number of servings consumed weekly and the corresponding dietary reference intake 
(DRI) values provided by the USDA for each food group(USDA, 2015). 
 
 
B-NHL subtype 
Cases 
(n) (%) 
DLBCL  217 70.7 
Follicular lymphoma 43 14.0 
Low grade  lymphoma 13 4.2 
SLL  12 3.9 
Mantle cell lymphoma 5 1.6 
MALT  lymphoma 4 1.3 
Marginal zone lymphoma 3 1.0 
Burkitt lymphoma 2 0.7 
Lymphoblastic  lymphoma 2 0.7 
Unspecified B- NHL 5 1.6 
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Table (5.4-a): Distribution of consumption of food groups for B-NHL cases and controls, 
medians and USDA’sDRI values of food groups. 
 
Food group Scale 
Patient Control 
DRI 
n (%) 
Median 
(servings/week) 
n (%) 
Median 
(servings/week) 
Fruits 
 
Never 3(1) 
5 
5(1.3) 
6 
2-4 
servings/ 
day 
<1aweek 11(3.7) 14(3.6) 
1 a week 21(7.1) 14(3.6) 
2- 4 a week 80(26.9) 92(23.9) 
5-6 a week 35(11.8) 43(11.2) 
1 a day 52(17.5) 91(23.6) 
>1 a day 95(32) 126(32.7) 
Vegetables Never 2(0.7) 
6  
1(0.3) 
6 
3-5 
servings/ 
day 
<1 a week 5(1.7) 5(1.3) 
1 a week 12(4) 6(1.6) 
2- 4 a week 64(21.5) 72(18.9) 
5-6 a week 34(11.4) 50(13.2) 
1 a day 64(21.5) 87(22.9) 
>1 a day 116(39.1) 159(41.8) 
Meat or 
chicken 
Never 1(0.3) 
4  
3(0.8) 
4 
2-3 
servings/ 
day 
<1 a week 11(3.7) 15(3.9) 
1 a week 30(10) 39(10.2) 
2- 4 a week 180(59.8) 252(65.6) 
5-6 a week 50(16.6) 40(10.4) 
1 a day 29(9.6) 32(8.3) 
>1 a day 0(0) 3(0.8) 
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Table (5.4-b): Distribution of consumption of food groups for B-NHL cases and controls, 
medians and USDA’sDRI values of food groups. 
 
Food group Scale 
Patient Control 
DRI 
n (%) 
Median 
(servings/week) 
n (%) 
Median 
(servings/week) 
Fish Never 18(6) 
2  
28(7.3) 
2 
2-4 
Servings/ 
week 
<1 a week 180(59.8) 211(55.2) 
1 a week 79(26.2) 112(29.3) 
2- 4 a week 23(7.6) 30(7.9) 
5-6 a week 1(0.3) 1(0.3) 
1 a day 0(0) 0(0) 
>1 a day 0(0) 0(0) 
Subtotal 301(100) 382(100) 
Whole milk Never 69(23) 
4  
128(33.8) 
2 
2-3 
Servings/ 
day 
<1 a week 55(18.3) 82(21.6) 
1/ week 14(4.7) 27(7.1) 
2- 4 / week 54(18) 49(12.9) 
5-6 /week 17(5.7) 14(3.7) 
1 a day 69(23) 66(17.4) 
>1 a day 22(7.3) 13(3.4) 
Dairy 
products 
Never 14(4.6) 
5  
15(3.9) 
5 
2-3 
servings/ 
day 
<1 a week 18(6) 38(9.9) 
1 a week 23(7.6) 32(8.3) 
2- 4 a week 76(25.2) 96(25) 
5-6 a week 41(13.6) 67(17.4) 
1 a day 102(33.8) 103(26.8) 
>1 a day 28(9.3) 33(8.6) 
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Fruits 
The median consumption of fruits by Palestinians cases in this study was 5 servings/week) 
and by controls is (6 servings/week) (Table 5.4), both groups showed median intake that is 
below the DRI which is 2-4 servings/day. A non-significant inverse association was 
noticed between fruit consumption and risk of B-NHL (OR=0.7; 95% CI: 0.2-2.1) (Table 
5.5), suggesting a protective effect for increased intake of fruits from the risk of B-NHL.  
 
Table (5.5): ORs and 95% CI for B-NHL association with consumption of food groups. 
 
Food group OR* 95% CI 
 Fruits 
1 Reference 
0.7 0.2 - 2.1 
Vegetables 
1 Reference 
1.3 0.4 - 4.0 
 Meat (red and white) 
1 Reference 
1.8 0.8 - 4.3 
 Fish  
1 Reference 
0.4 0.2 - 0.8 
 Whole milk  
1 Reference 
2.3 1.2 - 4.4 
 Dairy products  
1 Reference 
1.3 0.7 - 2.6 
* ORs: Odds ratios estimated from unconditional logistic regression adjusted for age and sex. 
 
Vegetables  
Regarding vegetable intake, the median intake for both cases and controls was also much 
below the DRI (6 servings/week compared to 3-5 servings/day) (Table 5.4). In addition, 
vegetable intake was found to be positively associated with risk of B-NHL (OR=1.3; 95% 
CI: 0.4-4) (Table 5.5).  
 
Meat 
According to Table (5.4)  the median meat intake was also found to be less than the DRI, 
nevertheless, a positive association between risk of B-NHL  and meat intake was found 
although it was non-significant (OR=1.8; 95% CI: 0.8-4.3) (Table 5.5). 
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Fish 
Fish consumption was the only one close to the DRI, though still at the lowest borders of 
consumption (Table 5.4).  A significant inverse association between fish consumption and 
B-NHL risk was found (OR=0.4; 95% CI: 0.2-0.8) (Table 5.5), which means that an 
increased fish intake might be protective against B-NHL. 
 
Whole milk  
As for whole milk consumption, the median of weekly intake was less than the DRI as 
shown in Table (5.4). Yet, higher intake of milk was found to be significantly associated 
with increased risk of B-NHL (OR=2.3; 95% CI: 1.2-4.4) (Table 5.5). 
 
Dairy products 
As with most of rest of the other food items included in this study, the median intake of 
dairy products in both cases and controls participating in this study was 5servings/week, 
which is also far below the DRI value of (2-3 servings/day) (Table 5.4). In addition, a 
higher intake of dairy products was non-significantly associated with an increased risk of 
B-NHL (OR=1.3; 95% CI: 0.7-2.6) (Table 5.5). 
 
5.4Personal and Family History of Cancer and the Risk of B-NHL 
 
A significant association between personal history of cancer and B-NHL risk was observed 
(OR=11.1; 95% C.I: 2.5-48.5) (Table 5.6), this means that a person with previous cancer is 
11 times more likely to develop B-NHL than those without a previous history of cancer. 
Table (5.6) also shows that family history of cancer among first degree relatives was found 
to be significantly associated with increased odds of B-NHL (OR=1.7; 95% C.I: 1.2-2.5). 
 
Table (5.6): ORs and 95% CI for B-NHL association with personal and family history of 
cancer. 
 
 
Case 
(n) 
Control 
(n) 
OR* 95% CI 
Personal history of cancer 
No 282 381 1 Reference 
Yes 17 2 11.1 2.5 - 48.5 
Family history of cancer in the 
first degree relatives 
No 218 299 1 Reference 
Yes 79 62 1.7 1.2 – 2.5 
* ORs: Odds ratios estimated from unconditional logistic regression and adjusted for age and sex 
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Chapter Six 
______________________________________________________________ 
Discussion, Conclusion, Limitations and Recommendations  
 
6.1Discussion 
 
Cancer is a major health problem in high, middle and low income countries, and is the 
second leading cause of death in the world(Al-Othman et al., 2015). Over the past several 
decades, a global rise in the incidence of NHL was noticed and recent studies reported that 
the diet may contribute to this rise(Skibola, 2007). This case–control study is the first to 
investigate B-NHL and dietary factor among the Palestinian population. 
 
The results of this study add valuable information on the subject and also lead to a better 
understanding of dietary consumption patterns and their implications in overall health and 
disease. In addition, the use of face to face interview-based questionnaire conducted by 
trained interviewers to fill the questionnaire provided more consistency to the process of 
data collection increasing the reliability and reproducibility of the study. Moreover, the 
study provides the base to conduct more researches regarding nutritional intake and food 
patterns among Palestinians and the etiological factors of NHL. 
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6.1.1 Socio-demographic characteristics 
An increase in the proportion of B-NHL cases was noticed with aging among Palestinians. 
Age is a major risk factor for NHL, and this result is consistent with the worldwide trends 
in NHL(Caimi, Barr, Berger, & Lazarus, 2010; Julius, 1987). Nevertheless, the results 
showed a mean age at diagnosis (years±SD) for B-NHL of(50.8±16.6) and a median age of 
52 years, with most cases being <65 years old and a large proportion of cases (more than 
20%) younger than 35 years old. The median age in this study is younger than the 
worldwide reported median (seer.cancer.gov/, 2014).  In addition, the regional variability 
in the distribution of Palestinian cases might be attributed to certain environmental or 
genetic exposure. 
 
In the present study, the educational level of cases was lower than that of the controls as 
most of cases had primary education levels while the majority of controls were either 
within the secondary education level or had a first university degree. The low educational 
level among the cases might be related to poor socio-economic status and less healthy 
conditions, which may contribute to the increase in the exposure to infections and 
consequently, may raise the risk of B-NHL. This result is in line with other studies(Allison, 
Daw, & Rorvik, 1987; Holly, Lele, Bracci, & McGrath, 1999), though some studies did not 
report a similar association(Franceschi et al., 1989; Hermann et al., 2010). 
 
The present study showed minor differences in the distribution of B-NHL cases and 
controls in relation to birth order in the family. An increase in birth order was reported to 
be associated with increased susceptibility to infections during early development of the 
immune system leading in turn to an increased risk of NHL(Vineis et al., 2000). Some 
previous studies reported weak or non-significant associations between large sibship and 
the risk of NHL(Vineis et al., 2000), while other case-control studies have reported that 
only children and first-born children had an approximately 50% reduction in NHL risk 
compared with fourth or later-born children and that NHL risk increased with increasing 
number of older siblings, for only children OR was 0.5 (95% CI:  0.3-0.8), for first-born 
children (OR=0.6; 95% CI: 0.4-0.8), for second-born children (OR=0.7; 95%  CI: 0.5-1.0) 
and for third-born children (OR=0.8; 95% CI: 0.6-1.1), however, markers of crowding later 
in childhood, such as bedroom and bed sharing, were not associated with risk of NHL 
(Grulich et al., 2005; Vineis et al., 2000). Other studies reported that a large sibship size, 
late birth order and childhood crowding were associated with an increase in B-NHL risk. 
 40   
 
Effect mechanisms may be related to early age at onset and high frequency of specific 
infections or microbial exposure in childhood(Bracci, Dalvi, & Holly, 2006; Smedby et al., 
2007). 
 
6.1.2Nutritional intake 
Our results showed that median intake for the assessed food groups for Palestinian cases 
and controls were below the DRI for most food groups,which is consistent with the 
findings of other previous study that assessed dietary intake among Palestinians(Abdeen et 
al., 2007). 
 
Regarding fruit consumption, a non-significant inverse association was found between 
higher intake of fruits and risk of B-NHL (OR=0.7; 95% CI: 0.2-2.1). This is in agreement 
with several previous studies (Davis, 1992; Holtan et al., 2012; Kelemen et al., 2006; 
Wang et al., 2007; Zheng et al., 2004). The protective effect of fruit intake on lowering the 
risk of SLL in women was reported by Purdue and his colleagues(Purdue et al., 2004). This 
association between fruit intake and B-NHL risk was explained by the antioxidant effect of 
certain components in fruits, which can prevent free radicals and inhibit nitrosation, 
especially of carotenoids, vitamins C, proanthocyanidins and manganese, leading in turn to 
the reduction of production of reactive oxygen species responsible for oxidative DNA 
damage, regulation of cell survival and apoptosis pathways and further improvement and  
protection of immune responses and immune system(Thompson et al., 2010). The 
protective role of fruits was also reported to be attributed to their content of folate, which 
prevents chromosomal breaks since it is considered an anti-carcinogenic molecule and is 
found mainly in fruits and vegetables(Liberski, 1987; Ollberding et al., 2012; Thompson et 
al., 2010). It is worth noting here that abnormal one carbon metabolism which is caused 
either by folate deficiency or through polymorphisms in folate metabolizing genes, may 
promote lymphomagenesis through mechanisms involving aberrant DNA synthesis, repair, 
and methylation(Chang et al., 2005; Kelemen et al., 2006; Skibola, 2007). Other studies, 
however, have not indicated any association between fruit intake and B-NHL risk (Ali et 
al., 2013; Chen et al., 2013; Ollberding et al., 2014). Similarly, no beneficial impact was 
found by Liberski (1987) for  fruit intake, which was relate to the fact that fruit generally 
contains less fiber, minerals, and vitamins and more sugar and calories (Liberski, 1987). 
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A positive association between increased vegetable intake and the risk of B-NHL was 
found in this study (OR=1.3; 95% CI: 0.4-4). Although  an increased risk for SLL have 
been previously reported to be associated to higher intake of vegetables(Lazar, Hodin, 
Darling, & Chin, 1988), but no similar positive association with vegetables, vegetable fat, 
dark green vegetables or high-nitrate vegetables and the risk of NHL was reported(Chiu et 
al., 1996, 2008; Ollberding et al., 2014). In contrast, most previous case-control and cohort 
studies reported an inverse association between intake of vegetables and the risk of NHL, 
an association that was explained by their anti-oxidant properties which cause reduction of 
reactive oxygen species which contributes in oxidative DNA damage, regulation of cell 
survival and apoptosis pathway, and protection of immune responses(Ali et al., 2013; 
Kelemen et al., 2006). Furthermore, dietary fibers was found to be inversely associated 
with risk of NHL and inhibit lymphoma development by suppressing inflammation that 
was indicated by serum levels of C-reactive protein, a clinical marker of 
inflammation(King, Egan, & Geesey, 2003; Zheng et al., 2004). In addition, the 
association between vegetable intake and lymphoma was found to differ by lymphoma 
subtype; Chiu et al (2011) reported that higher intake of cruciferous vegetables and green 
leafy vegetables was associated with a lower risk of NHL and in particular DLBCL 
(OR=0.4; 95%  CI: 0.2-0.8), while green leafy vegetable intake was associated with a 
lower risk of FL (OR=0.5; 95% CI: 0.3-0.8) and DLBCL (OR=0.5; 95% CI: 0.3-0.9)(Chiu 
et al., 2011). 
 
The positive association between vegetable intake and the risk of B-NHL found here could 
be attributed to the misuse of pesticides among Palestinian farmers and the lack of safety 
precautions(Alavanja et al., 2014; Schinasi & Leon, 2014), or  to the increasing use of 
wastewater in agriculture in Palestine. In fact, most agricultural land in the Palestinian 
National Authority  is used for food production where vegetables, orchards, and dry land 
crops are planted, and the problem of agricultural pesticides in  Palestine, in addition to 
Arab countries, is not only about uncontrolled use, but also attached to the unsafe handling, 
misuse and disposal of unwanted pesticides. In Palestine this effect is even amplified by 
the undeveloped national laws and regulations in regard to potential fate and the impact of 
residuals of pesticides on groundwater, food safety and public health (Bashour, 2008). 
Furthermore, the sale and handling of pesticides are not regulated and that accredited labs 
for pesticide residue analysis are not available(DeWaal & Robert, 2005). Further, the 
shortage of reliable data has alerted the scientific community and, to some extent, the 
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general public, to the need for facts on potential health hazards of pesticides through their 
indiscriminate use(Samhan & PWA, 2008). Moreover, most Palestinian agricultural 
workers have low level of knowledge regarding pesticide use, safety precautions and the 
protective measures; Al-Sa’ed and his colleagues assessed the knowledge of Palestinians 
about pesticide use and reported that 86.3% of respondents were not able to read 
instructions on pesticides’ labels as most of them are either in Hebrew or English, in 
addition to 95.4% that were found to rely on their own experience for the dose amount and 
calibration(Al-Sa‵ed, Ramlawi, & Salah, 2011). The misuse of these pesticides was 
reported in other studies to cause intoxication among exposed persons (Zyoud et al., 2010) 
and was also reported to be associated with increased NHL risk(Alavanja et al., 2014; 
Hohenadel et al., 2011; Sundewall et al., 1985). 
 
The existing condition of wastewater is considered to be disastrous for Palestinians as 
reported in other studies. Wastewater that seeps and infiltrates down from the individual 
cesspools to the groundwater aquifers causing groundwater pollution as well as spring 
pollution.  In addition, some farmers use the raw sewage to irrigate their vegetables, such 
as DeirSharaf’s farmers in Nablus area and Obedia’s farmers in Bethlehem area. This 
wastewater flows over soil surface and causes salt accumulation as well as suspended 
solids which is known to destroy the texture and the structure of the soil and might cause 
some diseases for human beings (Sbeih, 1996). A previous study reported that a long term 
exposure to elevated nitrate levels in drinking water may contribute to the risk of NHL 
(Ward et al., 1996), and another one conducted in China in 2012 reported that protecting 
groundwater from nitrogen contamination is an important public-health concern and a 
major national environmental issue(Halwani, Baroudi, & Wartel, 1998). The existing 
evidence suggest that the use of wastewater in crop irrigation increases their content of 
nitrates, and since nitrates and nitrites are precursors in the endogenous formation of N-
nitroso compounds, which are potent animal carcinogens, their increased intake might 
entail an increase in the risk of NHL among other serious health effects (Mousavi, Balali-
Mood, Riahi-Zanjani, & Sadeghi, 2013; Ward et al., 2010). 
 
Furthermore, a positive association between B-NHL risk and an increased meat intake was 
found (OR=1.8;95% CI: 0.8-4.3), a finding that is consistent with previous case-control 
and cohort studies that reported a positive association between a high-meat diet and high 
animal fat intake  and the risk of B-NHL, although meat consumption among Palestinians 
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was shown to be less than DRI(Ali et al., 2013; Ollberding et al., 2014; Purdue et al., 2004; 
Skibola, 2007; Zhang et al., 1999). Excessive meat intake, which is high in saturated fat, 
animal protein and calories, might lead to increased chronic antigen stimulation and altered 
immunocompetence and immune system impairment, it might also amplify the effect of 
certain viruses or genetic susceptibility(Morton, Hartge, et al., 2005), which in turn may 
lead to the development of lymphoma (Davis, 1992; Zheng et al., 2004). The suppressive 
effect of meat consumption to the immune system might be due to the presence of 
chemicals such as haem, which can damage the cells causing them to divide much more 
than normal to compensate for this damage and subsequently increase cancer risk (Cross et 
al., 2003). Haem could also stimulate the bacteria in the gut to produce N-nitroso 
compounds which are known carcinogens. Furthermore, consumption of cooked meat, 
either fried, grilled, or boiled, may influence NHL development through the generation of 
immunotoxic heterocyclic amines and other polycyclic aromatic (Layton et al., 1995). 
Saturated fats can also increase the risk of NHL and its subtypes by promoting 
inflammation via the cyclooxygenase and lipoxygenase pathways (Zheng et al., 2004). 
Moreover, a positive association between the intake of fried red meat in particular and 
NHL risk was reported with no association   between red or white meat intake and the risk 
of NHL(Chang et al., 2005).In contrast, no association between the consumption of meat, 
fat or chicken and NHL risk was reported in other studies(Daniel et al., 2012; Hansen, 
Casaburi, Cooper, & Wasserman, 1988; Rohrmann et al., 2011). 
 
Concerning fish consumption, a significant inverse association between fish consumption 
and B-NHL risk was found with an odds ratio of 0.4 (95% CI: 0.2-0.8). This finding is 
consistent with several case-control and cohort studies(Ali et al., 2013; Fritschi et al., 
2004; Hinrichs, Gaab, Feistner, Lorenz, & Dorfmuller, 1989; Skibola, 2007). In fact, fish 
oils have been used successfully in the management of several inflammatory and 
autoimmune diseases, which are risk factors of B-NHL(Kelley, 2001). On the other hand, a 
previous meta-analysis and a case-control study detected no association between 
consumption of fish and the risk of NHL(Chang et al., 2005; Yang et al., 2014). In 
contrast, other studies showed a positive association between the consumption of fish 
intake and B-NHL risk(Daniel et al., 2012; Yang et al., 2014), which was attributed to the 
high content of organochlorine pesticides and PCBs in some fish(Skibola, 2007). 
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A significant positive association between milk intake and B-NHL risk was found in this 
study (OR=2.3; 95% CI: 1.2-4.4). This is consistent with several previous studies(Chiu et 
al., 2008; Davis, 1992). Other studies reported a positive association between milk intake 
and DLBCL but not FL(Chiu et al., 2008). Moreover, milk types were reported to have 
varied effects on NHL risk; i.e. low fat milk was found to have a protective impact while 
fatty milk was a risk factor(Mallinger et al., 1987). An increased risk of NHL associated 
with a high fat diet may lead to altered immunocompetence, and immune system 
impairment by acting on the lipoxygenase, cyclogenase, cytochrome P-450 pathways or its 
direct effects on cell membrane function and structure, which lead to alteration in 
lymphocytes, and as a result, impaired immune function(Calder & Kew, 2002; Zheng et 
al., 2004). On the other hand, a beneficial effect for the milk pattern on SLL in women was 
reported(Purdue et al., 2004). In addition, skim milk was inversely associated with NHL 
risk and SLL. However, other studies found no association with NHL risk(Chiu et al., 
1996; Ward et al., 1994). 
 
With  regard to the association between the consumption of dairy products and B-NHL, a 
positive association between consumption of dairy products and the risk of B-NHL was 
found (OR=1.3; 95% CI: 0.7-2.6) and this result is in agreement with several previous 
studies (Skibola, 2007; Talamini et al., 2006).  The proposed mechanism of action for dairy 
products is through increased chronic antigen stimulation and altered immunocompetence 
and immune system impairment (Morton, Zheng, et al., 2005). Another mechanism could 
involve inhibition of 1,25(OH)2D production, which is the biologically active form of 
vitamin D and considered an anti-carcinogen because it promotes differentiation and 
apoptosis and inhibits cell growth in neoplastic cells. This inhibition occurs due to the 
calcium in dairy products. In addition, contamination of dairy fat with significant levels of 
organochlorines such as dioxins and polychlorinated biphenyls which are considered 
carcinogens and immunotoxins that can alter normal B-cell responses; positive associations 
between organochlorines and NHL suggest a role of dairy fat in lymphomagenesis 
(Skibola, 2007). In contrast, other studies reported no association between dairy 
consumption and B-NHL risk(Chiu et al., 1996; Ursin, Bjelke, Heuch, & Vollset, 1990). 
 
6.1.3 Personal and family history of cancer 
An elevated significant positive association was found between personal history of cancer 
and B-NHL risk (OR=11.1; 95% CI: 2.5-48.5). This result is consistent with several 
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previous studies(Crump et al., 2012; Paltiel et al., 2000; Wang et al., 2007); for example, a 
previous study reported that women with endometriosis were at an increased risk of 
hematopoietic malignancies, especially B-NHL. In addition, other studies reported an 
increase in the incidence of lymphomas in patients with gastric tumors (Rothman et al., 
2006; Skibola et al., 2007). Moreover, liver cancer, breast cancer and kidney cancer  were 
all reported to be associated with increased NHL risk(Linet et al., 2014; Negri et al., 2006; 
Skibola et al., 2014). 
 
The association between the risk of B-NHL and first degree relatives’ history of cancer 
was found to be significantly increased in this study. A multicenter U.S.-based case-control 
study of NHL was conducted to evaluate familial aggregation of NHL with various 
hematolymphoproliferative and other cancers, reported that a positive family history of 
NHL was associated with a 2-fold increased risk of NHL(Chatterjee et al., 2004; Linet & 
Pottern, 1992). Other studies reported that a familial history of NHL is significantly 
associated with increased risk for NHL and B-NHL subtypes like DLBCL and FL. In 
addition, NHL was found to have a stronger familial association among men than among 
women, and siblings were also a more strong marker of personal risk of NHL than is 
history of NHL in a parent(Altieri, Bermejo, & Hemminki, 2005; Wang et al., 2007; Zhu et 
al., 1998). 
 
6.2 Conclusion 
 
This study affirmed the role of aging in the etiology of NHL, which is consistent with the 
worldwide trends of NHL. Further, the findings of this study supports a possible 
contribution for dietary intake and nutritional factors in the process of lymphomagenesis;  
high consumption of meat, dairy products, milk and vegetables were all found to be 
associated with an increased risk of B-NHL, while fruit intake was found to reduce the risk 
of B-NHL. In addition, a significant protective effect of fish consumption and B-NHL risk 
was found. These findings need further investigation to be confirmed in larger studies, but 
they provide a base to study NHL in Palestine and the Arab region. 
 
6.3 Limitations 
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Despite the fact that this study is the first to investigate NHL in Palestine and one of few in 
the Arab world, and all the efforts provided to strengthen the design and outcomes of it; 
there remain some limitations that may affect the outcomes and the generalizability of this 
study.  
 
The most apparent limitation is the retrospective case-control designwhich is affected by 
recall bias. In addition, relying on self-reported consumption data and family history of 
cancermay result in a misclassification bias. The use of standardized face-to-face 
interview-based questionnaire for data collection by trained interviewers with both cases 
and controls limit the probability of differential bias, still the findings might suffer from 
non-differential bias that may lead to underestimation of the associations. 
 
Furthermore, in this study we were unable to evaluate the association between dietary 
intake and NHL subtypes due to the limited sample size in each subcategory. Moreover, 
the pathological diagnosis in the West Bank is not based on the-state-of art immuno-
staining. 
 
6.4 Recommendations 
 
Based on the findings of the study, further investigation regarding dietary factors patterns 
and the role in lymphoma risk using larger samples, more detailed questionnaires such as 
the 36 or 72- item FFQ, or 24-hour recall questionnaire, in addition to details regarding 
methods of food preparation which might also be a factor associated with NHL risk and is 
not investigated in this study. Further, it is worthy to investigate the postulated association 
for pesticide misuse, the use of untreated wastewater in agriculture, vegetable intake and 
the association with the risk of NHL. 
 
Public health efforts are recommended strongly to be directed towards developing better 
dietary habits that meets the recommended RDIs through public awareness programs for 
food safety and prevention of nutritional-associated health problems that include cancer, 
which is a shared responsibility between the Ministry of Health and the Ministry of 
Agriculture. 
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Controlling and monitoring for agricultural practices such as the use of pesticides for crops 
and livestock and the use of untreated wastewater for irrigation, which could be 
achievedthrough development of legislations and regulations and training programs for 
farmers to ensure safety of workers and consumers. 
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 اٌّٛافمخ ػٓ ػٍُ ٌٍّفبضوخ فٟ زضاؼخ
 ٚضَ اٌغسز اٌٍ١ّفبٚ٠خ
أُشبسًخ ك٢ دساعخ رجحش ك٢ أعجبة اُٞسّ اُِ٤ٔلبٝ١ ؿ٤ش اُٜٞدعٌٖ، ح٤ش  ُوذ ؽِت ٓ٘٢ 
عأشبسى ًحبُخ (ٓش٣غ اُز١ ُشِخَض ثٜزا أُشع) ، أًٝٔغٔٞػخ ػبثطخ ( شخض عِ٤ْ لا ٣ؼبٗ٢ 
ٖٓ ٛزا أُشع ، ٌُٖٝ ُذ٣ٚ طذ٣ن أٝ أحذ اكشاد ػبئِزٚ ٣ؼبُغٕٞ ك٢ ٛزا أُغزشل٠ ) .ٛزٙ اُذساعخ 
اُشخظ٤خ ، ٝاُزبس٣خ اُطج٢ ، ٝعجَ اُزؼشع. ٝرُي ُِ٘بط أُظبث٤ٖ  عٞف روبسٕ أُؼط٤بد 
ٝاُـ٤ش ٓظبث٤ٖ ثبُٔشع. ٛزٙ اُذساعخ ُذ٣ٜب اُوذسح ػِ٠ اًزشبف ٓؼِٞٓبد ٛبٓخ ػٖ أعجبة ٛزا 
 أُشع.
عٞف ٣طِت ٓ٘٢ الإعبثخ ػِ٠ أعئِخ رزؼِن ث٘لغ٢ ، ٝ رلبط٤ِ٢ اُطج٤خ ، ٝاُؼلاط ك٢  
أُغزشل٠ ثبُٔبػ٢ ،ٝ ػبئِز٢ ،ٝأ٣ٖ ػشذ ،ٝٝظبئل٢ اُز٢ ػِٔذ ثٜب ، عٔ٤غ أُؼِٞٓبد ك٢ ٛزا 
 .ده٤وخ أٝ أهَ 03الاعزج٤بٕ عزحزلع ثطبثغ ٖٓ اُغش٣خ. أُوبثِخ عزذّٝ حٞاُ٢ 
). اُذّ عٞف ٣لحض ٖٓ أعَ ثؼغ   "cc51"خ دّ (  حٞاُ٢أ٣ؼب ع٤طِت ٓ٘٢ روذ٣ْ ػ٤٘
اُخظبئض اُغ٤٘٤خ اُز٢ هذ رزؼِن ثٞسّ اُـذد اُِ٤ٔلبٝ٣خ ٝأ٣ؼب ع٤زْ كحظٚ لإطبثبد  ك٤شٝع٤خ 
عبثوخ ٝأُؼشٝف ثإٔ ُٜب ػلاهخ ثٞسّ اُـذد اُِ٤ٔلبٝ٣خ. أُؼِٞٓبد ٖٓ ٛزا اُلحض عزجو٠ عش٣خ 
خ ٗز٤غخ أخز ػ٤٘بد اُذّ. ٝلا ٣ٞعذ ٛ٘بى أ١ آصبس عبٗج٤خ أ٣ؼب . هذ ٣ٌٕٞ ٛ٘بى اُشؼٞسثؼذّ اُشاح
 أخشٟ ٓزٞهؼخ ٖٓ أُشبسًخ ك٢ ٛزٙ اُذساعخ.
 
 الإعْ:_________________________________
 اٝاكن ػِ٠ اعشاء أُوبثِخ ( اُزٞه٤غ ) ________________
 أٝاكن ػِ٠ إػطبء ػ٤٘خ اُذّ (اُزٞه٤غ)________________
ٕ ػ٤٘خ اُذّ اُز٢ عحجذ ٓ٘٢ ٝإٔ رغزخذّ ك٢ دساعبد لاحوخ (اُزٞه٤غ ) أٝاكن ػِ٠ إٔ رخض
 ____________
 اُزبس٣خ : ______________________________________
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Pathology questionnaire: 
Patient Name: _______________ 
Patient Code: _______________ 
1. Date of Diagnosis: ___/___ /___ 
2. Age at Diagnosis (years) : _____ 
3. Date of last follow up:____/____/_____ 
4. Hospital of diagnosis:  
1. Augusta Victoria        2.Nablus (National) 
3. Cancer Registry       4.Beit Jala5.other:_________ 
 
5. Histological diagnosis: 
 
1. DLBCL (large 
cell) 
6. SLL 11. Mycosis fungoides 
2. Follicular 7. Lymphoblastic 12. NHL 
3. MALT 8. Low grade lymphoma   13. Hodgkin lymphoma 
4. MANTLE 9. B-cell NHL 14. others:__________ 
5. Burkitt 10. T-cell lymphoma    
 
6. Immunostain:     A. T cell    B.BcellC.unspecified. 
 
1. IHC (P-Positive N- Negative) 
2.CD20   (P-Positive N- 
Negative) 
3.CD10 (P-Positive N- Negative) 
4.BCL6 (P-Positive N- Negative)  
5. BCL2 (P-Positive N- 
Negative) 
6. CD43(P-Positive N- Negative) 
7.CD79A (P-Positive N- 
Negative) 
8.CD5  (P-Positive N- Negative) 
9.CD23(P-Positive N- Negative) 
10.kappa  (P-Positive N- 
Negative) 
 
11.lambda (P-Positive N- Negative) 
12. CD22 (P-Positive N- Negative) 
13. CD19 (P-Positive N- Negative) 
14. CD30 (P-Positive N- Negative) 
15. CLA (P-Positive N- Negative) 
16. ALK (P-Positive N- Negative) 
17. CD3 (P-Positive N- Negative) 
18. CD2 (P-Positive N- Negative) 
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7. Site of biopsy:  
 
1. Lymph Nodes (LN): 
1.1.        Cervical LN 
1.2. Axillary LN 
1.3. Mediastinal &Hylum 
1.4. Para aortic LN 
1.5. Abdominal LN 
1.6. Inguinal LN 
1.7. Submandibular LN 
1.8. Other LN:_________ 
 
 
3. Organs:  
3.1.  Nasopharynx 
 3.2. Oropharynx 
 3.3. Thyroid 
 3.4. Lungs 
 3.5. Breast 
 3.6. Stomach 
 3.7. Colon 
 3.8. Small Intestine 
 3.9. Pancreas 
 3.10. testes 
 3.11. Ovaries 
 3.12. skin 
 3.13. Brain 
 3.14. Bone Marrow 
 3.15. Others organs: 
 
2. Lymphoid Organs: 
2.1.  Tonsils 
2.2. Spleen 
 
 
8. Spread  of disease: 
1. Nodal   2. Extra nodal  3. Undefined  
9. Stage : 
1. I 2.   II   3.  III  4.IV 
10. Presence of B-symptoms (fever, weight loss, night sweat)  
1. Yes      2.  No   3.  Unknown 
11. Treatment received: 
1. CHOP 
2. Rituximab 
3. Other Chemotherapy:__________________ 
4. Radiotherapy 
5. Surgery 
6. Transplantation: 6.1.Autologus  6.2. Allogenic 
12. LDH at diagnosis:_______ 
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Non-Hodgkin Lymphoma 
Interviewer name:  _______________________   Code  
Date of Interview: ____/____/____ 
Time Started _____: _____     Finished at _____:_____ 
Site of Interview: 1. Home 2. Hospital___________________3. Clinic 4.others 
 
Part I: Demographic Information 
 
I would like to ask you about your sociodemographic information including 
your marital status, education,  place of birth, and others 
 
Q1)  ID Number  
Q2) Interviewee Name:  
 
 
 
Q3) Gender:   1. Male    2. Female  
Q4) Date of Birth Year Month Day 
        
 
Q5) Marital status: 
1. Single    
2. First marriage   
3. Second marriage or more  
4. Divorced or separated  
5. Widowed    
 
Q6) How many births did you have? (including all living and dead)  
 
Q7) How many are alive?  
 
Q8) What were the causes of death  
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Q9) I would like to ask about the sex and birthdates of your children? 
Child 
Number 
Sex 
 
Date of Birth 
Day/Month/Year 
1   
2   
3   
4   
5   
6   
7   
8   
9   
10   
  1.Male  2.Female 
Q10) How many siblings do you have?  
 
Q11) What is your birth order in the family  
 
Q12) What is your religion? 
1. Muslim  
2. Jewish  
3. Christian  
4. others  
Q13) How many years did you complete in school?  
 
Q14) Before kindergarten did you go to: 
 1. Day care  
 2. Nursery school 
 3. Baby sitter who takes care of more than one child 
 4. Baby sitter at home 
 5. Mother stayed home 
Q15) Did you go to kindergarten? 
 1. Yes    2. No  
Q16) What is your highest diploma? 
1. Never went to school   2. Partial Primary   (< 6th grade)         3. Primary school completed       
4. Partial Secondary         5. High school completed                   6. Diploma                                   
7. Bachelor degree           8. Higher research degrees                   
Primary school: 1
st
 grade-6
th
 grade, Secondary school: 7
th
 grade-12
th
 grade) 
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Q17)Did you receive technical training? (If no go to 20) 
 1. Yes    2. No  
Q18) How long did you train?_______________ 
Q19) What was the profession that you trained for? ____________ 
Q20) Where were you, your parents and grandparents born? 
Relative Country City 
Interviewee   
Mother   
Father   
Grandfather (father side)   
Grandmother (father side)   
Grandfather (mother side)   
Grandmother (mother side)   
 
Part II: Job Information 
I would like to ask you about your previous jobs and about your current ones, 
what type of exposures did you have in that work? Please report if you switched 
positions within the same employer. Please report periods of unemployment, 
military services, maternity leave etc.), 
 
 
Q21) Are you currently employed?  
 1. Yes    2. No  
Q22) Before your illness, did you have a regular job? 
 1. Yes    2. No  
Occupation Start time Finish time Breaks Place Exposures 
1)What is your current 
occupation: 
     
2) What were your former 
jobs 
     
a.      
b.       
c.      
3) Were you ever occupied 
in one of the following? 
     
1. Agriculture & gardening      
1.Pesticides  2. Meat products  3. Organic solvents  4.inorganic Solvents  5. Gasoline  6. UV radiation           
7.Cosmic radiation  8.Ionizing radiation   9.electromagnetic radiation   10. Infectious agents / 
microorganisms  11. Animals      12.Antibiotics  13.Paints   14. Hair dyes  15. Asbestos  16.animal skin 
17. Glues   18.sunlight19. medicines (pharmaceticals)     20 flour dust     21 cleaning materials      22. 
wood dust     23.Other 
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Exposures codes: 
1.Pesticides  2. Meat products  3. Organic solvents  4.inorganic Solvents  5. Gasoline  6. UV radiation           
7.Cosmic radiation  8.Ionizing radiation   9.electromagnetic radiation   10. Infectious agents / 
microorganisms  11. Animals      12.Antibiotics  13.Paints   14. Hair dyes  15. Asbestos  16.animal skin 
17. Glues   18.sunlight19. medicines (pharmaceticals)     20 flour dust     21 cleaning materials      22. 
wood dust     23.Others 
 
 
 
 
 
 
  
2. Teacher      
3. Textile      
4. Wood industry      
5. Flour workers      
6. Dry cleaning      
7. Chemical Industry      
8.Gasoline/ petroleum 
workers 
     
9. Lab technicians      
10.Health care provider  
a. doctors 
b. nurses 
c. physiotherapist 
     
11. Photoimager      
12. Veterinary      
13. Air crew      
14. Butcher      
15. Hair dresser      
16.Asbestos worker      
17. Leather worker      
18. Construction Workers      
19 Cleaners      
20. House wives      
21. others: 
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Part III: Housing 
I would like to have some information about your current and previous residences 
Q23) What type of residence have you lived in? 
(do not include residence of less than 3 years) 
 
Addresses Type of 
settle-
ment 
House 
type 
Which 
storey did 
you live on 
Water 
source 
# of persons 
residing in 
the house 
# of 
rooms 
Bath-
room 
From what 
year to what 
year? 
Current 
Residence 
        
Previous 
1. 
        
2.         
3.         
4.          
5.          
 Type of settlement :1. City >100000 persons 2.Town 20000-99999 persons 3.Small 
town 5000-19999 persons 4.village<5000 persons 5.agricultural settlement 6.private 
farm or rural dwelling 7. Other 
 House type:1. a private house 2. A multifamily (10 families) house 3.an apartment 
building (>10 families)  4. tent  5.agricultural settlement 
 Storey:1. ground floor 2. second floor  3.third floor 4.  higher floor  
 Drinking water source:1. pipes  2. a well  3. cisterns  4. mineral water 5. don’t know 
 Bathroom:1. indoors  2. outdoors 
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Part IV: Habits 
I would like to ask you about some of your personal characteristics as your measurements, 
and other habits as smoking, hair dying,  sun exposure, and your diet 
Q24) What are your measurements?  
Parameter Measurement  Measurement(before 10yrs) 
Height    
Weight   
1:the same          2: much higher3:somewhat higher (<10%)          4:much lower somewhat lower(10%) 
Q25) Have you ever smoked? (if never, go to Q31)  
1. Cigarettes    
2. Nargilah   
3. Pipes   
4. Tobacco   
5. Never smoked  
Q26) Are you a smoker now? 
1. Yes    2. No  
Q27) Have you stopped smoking? 
1. Yes    2. No  
Q28) How many years did you smoke? 
 
 
Q29) How many cigarettes do (did) you smoke per day? 
Period of time Number of cigarettes 
Average of smoking before illness  
Current level of smoking  
 1:  less than 10  2:   11-20  3: 21-40  4:more than 40 
Q30) What is the average of your  smoking, before illness and currently? 
Period if time Nargilah pipes Tobacco 
Before illness    
Currently    
 1: everyday 2: more than once/week 3: less than once/week 
Q31) Did you ever dye your hair?(if No go to37) 
1. Yes    2. No  
Q32) Do you dye your hair regularly? 
1. Yes    2. No  
 
 Q33) At what age did you begin to dye your hair?  
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Q34) On average, how many times do you dye your hair? 
1. less than once/yr 2. one-three times/yr 3. four-six times/yr 4. more than 
seven times/yr 
Q35) What color do you use in general? 
 1. black 2. brown 3. blonde 4. henna color 5. others 
Q36) Is the dye that you use artificial? 
1. Yes    2. No  
Q37)Did you ever have a severe sun burn in childhood? 
1. Yes    2. No  
Q38) How many hours per week do (did) you expose to sunlight 
outdoor not as part of your work but  including your leisure time  and 
your travelling to and from the work? 
 
Q39) When you are out of door, is your head covered? 
 1. always  2. most of the times  3. sometimes 4. Never 
Q40) When you are out of door, do you wear long sleeves? 
 1. always  2. most of the times  3. sometimes 4. Never 
Q41) Do you use sun screen when you go out in the sun 
 1. always  2. most of the times  3. sometimes 4. Never 
Q42) Were you breast fed? 
 1. Yes   2. No ‘  3. Don’t know  
Q43) Have you ever been vegetarian? (if no, go to Q45) 
 1.  Yes   2. No   
Q44) How many years have you been vegetarian?  
Q45) Do you eat meat regularly ?  
 1.  Yes   2. No   
Q46) How many times a week do you eat met?  
Q47) How many fruits per day do you eat on average? 
 1:zero   2:1-3  3: 4-7  4: more than 7 
Q48) How many vegetables do you eat per day on average?  
 1:zero   2:1-3  3: 4-7  4:more than 7 
Q49)What kind of oil do you mainly cook with?  
1. olive  2: soya  3: canola 4:sunflower   5:other ________ 
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Q50) How often do you usually eat or drink...? Please tick one box for each line 
 1)  2)  3)  4)  5)  6)  7)  8)  
never <1/wk 1/wk 
2-4X/ 
week 
5-6X/  
week 
1/day >1/day 
Number of 
servings per 
day 
Fruits         
Vegetables         
Meat or chicken         
Fish         
Whole milk 
What about reduced 
fat milk 
        
Other milk products 
(like yogurt, cheese, 
chocolate milk, 
pudding 
        
drink water         ___glasses 
Other non-alcoholic 
drinks (hot or cold) 
       ___glasses 
Alcoholic drinks        ___glasses 
 
 
Part V: Hobbies 
We would like to ask you about your hobbies that you used to practice, like the physical 
activities, arts, and others. 
 
Q51) During the last 10 years, have you practiced regular physical activity? (if not, go to 
Q55) 
 1. Yes     2. No   
Q52) What type of activity have you practiced?  
 1. Strenuous (like Jogging)   
2. Moderate (like walking)   
3. Light (like gardening)   
Q53) How often did you perform physical activity ? 
 1. Three times a week or more  
 2. Two times a week   
 3. Once a week    
 4. Less than this   
Q54) Did you practice any of the following physical activities, and how often? 
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Q55) Do you keep a garden as a hobby? (if not, go to Q64) 
 1.  Yes    2. No   
Q56) What type of gardening do you perform?  
 1. Indoor   2. Outdoor  
Q57) How many years have you practiced gardening?  
Q58) How many hours per week did you practice gardening? 
 1. less than 10 hours/week  
 2. 10-20 hours/week   
 3. more than 20 hours/week  
Q59) Do (did) you grow fruits and vegetables? 
1. For your own use     
2. For sale      
3. Do not grow fruits and vegetables   
2 times a 
week or 
more 
About 
once a 
week  
2. 2-3 
times a 
month or 
more 
seldom  
1. Don’t 
do this 
activity 
Physical Activities # 
    Football, handball, basketball, 
tennis, hockey or other ball 
games  
1 
    Athletics, gymnastics 2 
    Aerobics / fitness club 
exercise/Trade mill at home 
3 
    Jogging, running 4 
    Karate, Judo taekwondo 5 
    Wrestling 6 
    Boxing/Kick boxing 7 
    Weightlifting/Weight-training 8 
    Dancing (disco, techno, 
folkdance, line dance, ballet)   
9 
    Camping 10 
    Swimming 11 
    Cycling  12 
    Climbing 13 
    skateboarding, roller skating 14 
    Hiking, fishing 15 
    Water activities (sailing, surfing, 
water-skiing) 
16 
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Q60) Do (did) you use pesticides? (if not, go to Q64) 
 1.  Yes    2. No   
Q61)Do (did) you wear protective gloves and wearing when you use pesticides? 
1.all the time 2.most of the time 3. sometime  4. never 
Q62)Do (did) you wash your hands after using pesticides? 
1.all the time 2.most of the time 3. sometime  4. never 
Q63) Your pesticides are (were) against: 
 1. weeds   2. insects   3. fungus   4. don’t know   
Q64) Do (did) you spray insecticides in your house? 
1.≥1time/week  2.<1time/week-1time/month  3. few times/year 4. 
never 
Q65)Do you remember the name of the pesticide(s) whether being used in the house or in 
gardening? (if No go to 67) 
 1.  Yes    2. No   
Q66) What is(are) the name of the pesticide(s) did you use? 
Name of Pesticide 
 
 
 
 
 
Q67) When you were a baby or a small child, did you go to the agricultural field with your 
parents or older siblings?  
 1.  Yes    2. No   
Q68) Do (did) you practice art as a hobby? (if not, go to Q75) 
 1.  Yes    2. No  
 
Q69) What type of art do (did) you practice?  
 1. painting    
2. sculpture    
3. pottery and ceramics     
4. glasswork    
5. lithography and prints  
6. iron work    
7. Model making   
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Q70) In your hobbies were (are) you exposed to any of the following chemicals?  
 1. oil paints 
 2. acrylic paints 
 3. other paints 
` 4. Solvents (as  turpentine, kerosene, glues, dust, lead)____________ 
 
Q71) How many years did you practice this art?  
 
Q72) At what age did you start practicing this art?  
 
Q73) At what age did you stop practicing this art?  
 
Q74) How many hours per week did you practice this art? 
 1. less than 10 hours/week  
 2. 10-20 hours/week   
 3. more than 20 hours/week  
 
 
Q75) Do (did) you have other hobbies that involve the use of chemicals? (if not, go to Q80) 
 1.  Yes    2. No   
 
Q76) What is this hobby?   
 
 
Q77) What type of chemical is involved in this hobby?  
 
Q78) At what age did you practice this hobby?   
 
Q79) How many hours per week do (did) you practice this hobby? 
 1. less than 10 hours/week  
 2. 10-20 hours/week   
 3. more than 20 hours/week  
 
 
 
 
 
 
 76   
 
Part V: Health 
Now I am going to ask you about your health 
 
 
Q80) Have you ever suffered form diarrhea lasting more than two days? (if not, go 
to Q82) 
 1. Yes    2. No   3.Don’t remember 
Q81) Did you have any serious diarrhea from any of the following agents: 
Causative agent 
Number of 
times 
When was your last 
infection 
1. Salmonella   
2. Shigella                                                     
3. Campylobacter                                           
4. Yersinia                                                      
5. Strongiloidosis                                           
6. Ameba                                                       
7. Other parasitic infection                            
8. E.coli                                                         
9. I was told it was a viral infection              
10. They did not find the causative agent     
11. They didn’t check                                    
12.Other                                                        
Q82) Did you have a serious infection that required hospitalization during infancy 
(before the first year of age)? 
 1.  Yes   2. No 
Q83) Did you ever have any other serious infections that required hospitalization 
(like pneumonia)?(if no go to Q86) 
 1.  Yes   2. No 
Q84) How many times were you hospitalized for infections and at what age? 
Age # of times Type of infection 
1.more than 40 yrs   
2. 21-40yrs   
3. 11-20 yrs   
4. 1-10 yrs   
5. less than 1yr   
Infection codes 
1.  sinusitis 2.  bronchitis  3.  enteritis 4.  gall bladder infection   
5.  urinary tract infection  6.  prostatitis (men only) 7.  anal infection 8.  
dermatitis 9. gynecologic infection (women only) 10: meningitis 11. appendicitis 
12.other 
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Q85) Apart from  infections requiring hospitalization, did you suffer from any of 
the following disease(s)? If yes, when? 
 
Disease Yes No Don't remember Age 
1. Hepatitis A     
2. Hepatitis B     
3. Hepatitis C     
4. Herpes: lips, nose, ear, other     
5. Infectious Mononucleosis     
6. Asthma     
7. Eczema     
8. Tonsillitis     
9. Measles     
10. Mumps     
11. Rubella     
12.Rhreumatic fever     
13. Arthritis     
14. Tuberculosis     
15. Brucellosis     
16. Sinusitis     
17. Enteritis     
18. Polio     
19. Typhus     
20. Ulcer     
21. Allergy     
22. other     
Infection time code: 
1.more than 40yrs 2. 21-40yrs 3. > 11-20yrs  4. 1-10yrs 5. less than 1yr 
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Q86) Did you receive vaccinations to the following microorganisms? 
Disease Yes No Don't 
remember 
Age of the first 
vaccination 
Age of the last 
vaccination 
1. Tetanus      
2. Small Pox      
3. Typhoid      
4. measles      
5. Mumps      
6. Rubella      
7. Whooping cough      
8. Polio injection      
9. Polio drinking      
10. TB/BCG      
11. Yellow Fever      
12. Viral meningitis      
13. Cholera      
14. Hepatitis A      
15. Hepatitis B      
16. Hemophilus      
17. Pneumococcus      
18. Influenza      
19. others      
 
 
Q87) Did you undergo tonsillectomy? (if not, go to Q89) 
 1.  Yes   2. No  
 
Q88) At what age ?  
 
 
Q89) Were (have) you ever administered antibiotics ? (if not, go to Q91 )  
 1.  Yes   2. No  3. Don't know  
 
Q90) On average, how many times per year  were you administered antibiotics and at 
what age? 
Age # of times 
1.more than 40 yrs  
2. 21-40yrs  
3. 11-20 yrs  
4. 1-10 yrs  
5. less than 1yr  
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Q91) Did you ever have an X-ray?  
 1.  Yes   2. No  3. don’t remember 
 
Q92) Why did you perform an X-ray?   
X-ray # of times Age 
1. dental x-rays   
2. Chest x-rays   
3. Mammorgraphy 
(women) 
  
4. Bone x-rays   
5. Other   
1. >40yrs 2. 21-40yrs 3.> 11-20yrs  4. 1-10yrs 5. less than 1yr 
 
Q93)Which one of the following sentences describes your childhood the best up to 
18?  
1. I was sick more often than my friends     
2. I was away from school more than my friends     
3. I got more medications than my brothers and sisters   
4. I was a healthy child other than the normal childhood diseases  
5. I was sick much less often than my siblings and friends 
 
Q94) Did you have  pets or large animals at home or on the grounds of your home?  
(if not, go to Q96) 
 1.  Yes   2. No  
Q95)What type of animal (do) did you have? 
 1. cat   
 2. dog   
 3. bird   
 4. horse           
 5. cow   
 6. camel  
 7. goat   
 8. sheep  
 9. donkey  
 10. pig   
 11. others  
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Q96) Have (were) you ever prescribed any of the following medications? if yes, at 
what  age and how many times? 
1. Yes  2. No  3. Don’t Know 
Medication Never Occasional 
<1/wk 
Regular 
Year 
started 
Year ended 
1. Steroids      
2. Contraceptives     
3. Hormone replacement 
therapy 
    
4. Other hormones     
5. Antifungal (oral)      
6. Non-steroidal anti-
inflammatory  
    
7. Paracetamols      
8. Antidepressants      
9. Anti-parasitic      
10. Anti-anxiety      
11. Antiviral      
12. antihistamines      
13. B-Blockers      
14. Diuretics      
15. Anti-hypertensive 
drugs  
    
16. Thyroid replacement      
17.Anticoagulants      
18. Aspirin     
19.Chemotherapy      
20. Others      
Q97) Were you ever transfused with blood? 
 1.  Yes   2. No  3.Don’t know 
Q98) Prior to your current illness, did you ever have cancer? (if not, go to Q100) 
 1.  Yes   2. No  
Q99) What was the treatment you  received?  
 1. Chemotherapy  
2. Surgery   
3. Radiotherapy  
4. Don’t know   
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Q100) Did any of your first degree relatives have cancer? If yes, what was the 
cancer type and who was that? 
1. Yes   2. No   3. Don’t Know 
Cancer type Siblings Mother Father Child 1 Child 2 Child 3 
1. Any Cancer       
2. Non Hodgkins Lymphoma       
3. Hodgkins Lymphoma       
4. CLL       
5. ALL       
6. Multiple Myeloma       
7. Acute Myeloid Leukemia (AML)       
8. CML       
9.Blood cancer       
10. Other blood problems       
 
 
Q101) Did any of your second degree relatives have cancer? If yes, what was the 
cancer type and who was that? 
1. Yes   2. No  3. Don’t Know   
 
GM(m):  grandmother on mother’s side                   GF(m):  grandfather on 
mother’s side 
GM(f):  grandmother on father’s side                      GF(f):  grandfather on father’s 
side 
 
 
 
 
 
 
Cancer type GM/
m 
 
GF/m GM/f GF/f Uncles aunts cousins/n
ephew 
Nieces 
1. Any Cancer         
2. Non Hodgkins Lymphoma         
3. Hodgkins Lymphoma         
4. CLL         
5. ALL         
6. Multiple Myeloma         
7. Acute Myeloid Leukemia 
(AML) 
        
8. CML         
9.Blood cancer         
10. Other blood problems         
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Q102) Did any of your first degree relatives suffer from any of the following 
diseases? (If yes, who was that) 
1. Yes   2. No   3. Don’t Know 
Disease Siblings Mother Father Child 1 Child 2 Child 3 
1. Frequent Infection       
2. Allergy       
3. Rheumatoid Arthritis       
4. Autoimmune diseases       
5. Other immune problems       
 
Q103) Did any of your second degree relatives suffered from any of the following 
diseases? (If yes, who was that?) 
1. Yes  2. No  3. Don’t Know 
Disease GM/m 
 
GF/
m 
GM/f GF/f uncles aunts cousins/n
ephew 
Nieces 
1. Frequent Infection         
2. Allergy         
3. Arthritis         
4. Autoimmune diseases         
5. Other immune 
problems 
        
GM(m):  grandmother on mother’s side 
GF(m):  grandfather on mother’s side 
GM(f):  grandmother on father’s side 
GF(f):  grandfather on father’s side 
Q104) How often do you go to the dentist? 
1. For regular check-ups (at least once a year)   
2. For regular check-ups (less than once a year)  
3. Only when I have a toothache or other problem  
4. Never   
Q105) Do you own a car? 
 1. Yes   2. No  
Q106) How did you get to the hospital today? 
1.Walk  2. Private car  3. Taxi  4.Public Transportation 
 5.Other 
Q107) When is your next visit?  
Thank you very much for you co-operation. 
Q108) Interviewer rating of interview 
1. Highly reliable                         
2. Somewhat reliable    
3. Somewhat unreliable   
4. Unreliable  
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Appendix 4.3 
____________________________________________________________  
Study questionnaire in Arabic 
 
  
   48 
 
 
  غ١ط ٘ٛزعىٓاٌاٌٛضَ اٌٍ١ّفبٚٞ 
 amohpmyL nikgdoH-noN
 
 
 
 __________________  :اٌّمبثٍخاٌصٞ أعطٜ اٌفرك 
 
 : __________________ اٌصٞ أعطٜ اٌّمبثٍخوٛز اٌفرك 
 
      رٛل١غ اٌّٛافمخ ػٓ ػٍُ ٌٍّفبضوخ  ً٘ رُ؟ 
 
     ضلُ اٌفرك اٌّفبضن ػٍٝ الاؼزج١بْ ئٌمبق
 
     ػٍٝ أٔبث١ت اٌسَ ضلُ اٌفرك اٌّفبضن ئٌمبق
  
    ػٍٝ الاؼزج١بْ اٌجبصٌٛٛعٟ ضلُ اٌفرك اٌّفبضن ئٌمبق 
     ؼحت صلاس أٔبث١ت حّط ٚأجٛث١ٓ ثٕفؽغ١١ٓ
 اؼُ اٌفرك اٌّفبضن:_________________________ 
 ضلُ اٌفرك اٌّفبضن: _________________________
 ضلُ اٌٙبرف:________________________________ 
 ضلُ اٌرٍٛٞ: _______________________________
 اؼُ اٌطج١ت اٌّؼبٌظ: __________________________
 
 -اٌّمبثٍخِؼٍِٛبد 
 
 ____/____/____ ربض٠د اٌّمبثٍخ:  
 
 _____:_____ اٌّمبثٍخٚلذ ثسا٠خ 
 
 _____:_____ اٌّمبثٍخٚلذ ئٙب٠خ 
 
 ِىبْ اٌّمبثٍخ 
   إٌّعي .1
 _____________________          اٌّؽزففٝ .2
   اٌؼ١بزح .3
 _____________________   فٟ ِىبْ أذط .4
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 اٌمؽُ الأٚي :  اٌّؼٍِٛبد اٌؽىبٔ١خ
 
 :ٌٍّغّٛػخ اٌىبثطخ فمً 
 ____________________ )?ُٔش٣غ أخش /ٓشاكن (ُٔش٣غ ُٔلٞٓب أٗذَٛ 
 
 ____________________   ُِٔش٣غٓب ٛ٢ طِخ هشاثزي 
 
 
 
أٚز أْ أؼأٌه حٛي ِؼٍِٛبره اٌس٠ّٛغطاف١خ ٚاٌزٟ رزىّٓ اٌحبٌخ الاعزّبػ١خ ، اٌزؼٍ١ُ  ، 
 ٚ ِؼٍِٛبد أذطٜ. ِىبْ اٌٛلازح
 
 )ضلُ اٌفرك اٌّفبضن1غ 
 
 
 ِٓ اؼُ اٌفرك اٌّفبضن الأحطفبلأٌٚٝ) 2غ 
 
 
 .أٔضٝ2.شوط          1 ) اٌغٕػ :   3غ 
 
 ) ربض٠د اٌّ١لاز4غ  اُ٤ّٞ اُشٜش اُغ٘خ
        
 
 ) اٌحبٌخ الاعزّبػ١خ :5غ 
    أػضة .1
   ٓزضٝط ُٔشح ٝاحذح .2
   ٓزضٝط ُٔشر٤ٖ  أٝ أًضش .3
   ٓطِن أٝ ٓ٘لظَ .4
  أسَٓ .5
    
 
) وُ ٌِٛٛز ٌس٠ه ؟ (٠زىّٓ الأح١بء ُِٕٙ ٚاٌّزٛفْٛ ٚ لا ٠فًّ 6غ
 )الإعٙبن
 
 
 ) وُ ػسز الأح١بء؟    7غ 
 
 
 ) ِب ٟ٘ أؼجبة اٌٛفبح ؟8غ 
 
________________________________________________________________
 _____
________________________________________________________________ 
 _____
________________________________________________________________ 
 _____
________________________________________________________________ 
 _____
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 ) أٚز أْ أؼأٌه حٛي رٛاض٠د ِ١لاز أيفبٌه ٚعٕؽُٙ ؟ 9غ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 أٗض٠.  2   رًش.1 ***
 
  ) وُ  ػسز الأـمبء ػٕسن؟ 01غ 
 
  ) ِب ٘ٛ رطر١جه فٟ اٌؼبئٍخ ؟ 11غ 
 
 ؟) ِب ٘ٛ ز٠ٕه21غ 
     ٓغِْ    .1
  ٓغ٤ح٢     .2
   أخش .3
 
  ) وُ ػسز ؼٕٛاد اٌسضاؼخ  فٟ اٌّسضؼخ  ؟31غ 
 
 ) لجً اٌطٚوخ ً٘ ش٘جذ ئٌٝ :41غ 
     ٓشًض اُشػب٣خ اُ٤ٞٓ٤خ .1
      اُحؼبٗخ .2
  حبػ٘خ أؽلبٍ ٝاُز٢ رؼز٘٢ ثأًضش ٖٓ ؽلَ ٝاحذ .3
    حبػ٘خ أؽلبٍ ك٢ اُج٤ذ .4
   اُجوبء ٓغ الأّ ك٢ أُ٘ضٍ .5
 
 ) ً٘ ش٘جذ ئٌٝ اٌطٚوخ؟51غ 
 لا  .2.ٗؼْ                   1
 
 ) ِب ٟ٘ أػٍٝ ـٙبزح ػٍّ١خ حمٍذ ػٍ١ٙب ؟61غ 
 اُظق اُضبٗ٢ ػشش –: اُظق اُغبثغ اٌّطحٍخ اٌضبٔٛ٠خ اُظق اُغبدط ،      –اُظق الأٍٝ اٌّطحٍخ الأؼبؼ١خ : 
 ربض٠د اٌّ١لاز
 
 اٌغٕػ 
 
ضلُ 
 اٌطفً
 ٣ّٞ شٜش ع٘خ
 1    
 2    
 3    
 4    
 5    
 6    
 7    
 8    
 9    
 01    
 اُذساعخ الأعبع٤خ           أًِٔذ.3 اُظق اُغبدط) >( . أعبع٢ عضئ٢ 2 أُذسعخ   إُ٠.ُْ أرٛت 1
 . دثِّٞ                                6 . أًِٔذ اُذساعخ اُضبٗٞ٣خ5 .صبٗٞ١ عضئ٢            4
 خ           عضئ٤ أًبد٣ٔ٤خ  دسعخ . 9 . دسعبد ػِ٤ب                           8 . دسعخ اُجٌبُٞس٣ٞط7
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 ) 02غ  اش٘جاٌٝ" لا " ،  الإعبثخ) ً٘ رٍم١ذ رسض٠جب رمٕ١ب ؟   ( ئشا وبٔذ 71غ
 
 . لا 2.ٗؼْ                   1
 
 
 ______________________) وُ وبٔذ ِسح اٌزسض٠ت ؟ 11غ 
 
 
 ) ِب ٟ٘ إٌّٙخ اٌزٟ رسضثذ  ػٍ١ٙب؟ ___________91غ 
 
 
 
 آثبؤن ٚ أعسازن
 
 
  ٚأ٠ٓ ٌٚس أعسازن؟ آثبؤن) أ٠ٓ ٌٚسد ٚ أ٠ٓ ٌٚس 02غ 
 
 
 
 
 
 
 اٌمؽُ اٌضبٟٔ : اٌّؼٍِٛبد اٌٛظ١ف١خ
 
اُز٢ رؼشػذ (  الأش٤بء/أٝد إٔ أعأُي حٍٞ ػِٔي اُغبثن ٝػِٔي اُحبُ٢ ، ٓب ٛ٢ اُؼ٘بطش 
رزؼشع) ُٜب خلاٍ ػِٔي؟ (لا رشَٔ اُٞظبئق اُز٢ ػِٔذ ك٤ٜب ُٔذح روَ ػٖ عزخ أشٜش . سعبًء أثِـ٘ب 
ػٖ  الاٗوطبعك٤ٔب إرا ؿ٤شد ٓٞهؼي داخَ اُؼَٔ ٗلغٚ . سعبًء  أثِـ٘ب ػٖ كزشاد اُجطبُخ ، ٝكزشاد 
 .)اُؼَٔ،  ٝإعبصح الأٓٞٓخ اُخ 
 
 
 
 ) ً٘ ٌس٠ه ٚظ١فخ حبٌ١ب؟12غ 
 
 لا  .2   ٗؼْ.1
 
 
 ) لجً ِطوه ، ً٘ وبْ ػٕسن ػًّ ِٕزظُ؟22غ 
 
 لا .2   ٗؼْ.1
  
 اٌمط٠ت اٌسٌٚخ اٌّس٠ٕخ
 اُشخض أُوبثَ  
 الأّ  
 الأة  
 اُغذ  ( ٖٓ عٜخ الأة )  
 اُغذح ( ٖٓ عٜخ الأة )  
 ( ٖٓ عٜخ الأّ )  اُغذ  
 ) الأّاُغذح ( ٖٓ عٜخ   
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 ضِٛظ اٌزؼطن :***
 
. أُز٣جبد ؿ٤ش 4   . أُز٣جبد اُؼؼٞ٣خ3   . ٓ٘زغبد اُِحّٞ2   . أُج٤ذاد اُحشش٣خ1
  اُؼؼٞ٣خ
. الإشؼبع اُ٘برظ 8   . الإشؼبع اٌُٞٗ٢    7  . الأشؼخ كٞم اُج٘لغغ٤خ  6  اُج٘ض٣ٖ ٝ اُ٘وؾ ٝٓشزوبرٚ.5
  ػٖ اُزأ٣٤ٖ
. أُؼبداد 21   . اُح٤ٞاٗبد  11 .  أُ٤ٌشٝثبد / اٌُبئ٘بد اُذه٤وخ 01  أُٞعبد أُـ٘بؽ٤غ٤خ .9
عِذ  . 61  الأعجغزٞط   .51   أطجبؽ اُشؼش    .41  .الأؽِ٤خ/اُذٛبٕ   31    اُح٤ٞ٣خ  
   اُح٤ٞاٗبد
 . ؿجبس اُطح٤ٖ   02  الأدٝ٣خ. 91   ػٞء اُشٔظ  .81  الأطٔبؽ .71
 .أخشٟ32    . ؿجبس اُخشت  22  .  ٓٞاد اُز٘ظ٤ق12
 فزطاد اٌّىبْ اٌزؼطن ٌـ
 الأمطبع
ربض٠د 
 الأزٙبء
ربض٠د  
 اٌجسا٠خ
 اٌؼًّ 
 ِب ٘ٛ ػٍّه اٌحبٌٟ؟____________ )1     
 
 
 ِب ٟ٘ ٚظبئفه اٌؽبثمخ؟ )2     
 أ.     
 ة.     
 ط.     
 د.     
اٌّغبلاد  ئحسًٜ٘ ؼجك ٌه أْ ػٍّذ فٟ  )3     
 ؟ا٢ر١خ
 اُضساػخ ٝاُجغز٘خ .1     
 اُزؼِ٤ْ .2     
 اُ٘غ٤ظ .3     
 ط٘بػخ اُخشت .4     
 ػٔبٍ ؽح٤ٖ .5     
 اُز٘ظ٤ق اُغبف .6     
 اُظ٘بػخ اٌُ٤ٔبٝ٣خ .7     
 اُج٘ض٣ٖ / ػٔبٍ ٗلؾ .8     
 ك٘٤ٞ  أُخزجش .9     
 ٓوذّ خذٓبد اُشػب٣خ اُظح٤خ  .01     
 أ.الأؽجبء
 ة.أُٔشػ٤ٖ
 .ك٘٤ٞ اُؼلاط اُطج٤ؼ٢1
 ك٘٤ٞ الأشؼخ .11     
 ؽج٤ت ث٤طش١ .21     
 أُلاح٤ٖ ٝالاؽوْ اُغٞ٣خ  .31     
 اُغضاس ( اُِحبّ ) .41     
 اٌُٞاك٤شح )  /ٓض٣ٖ اُشؼش ( اٌُٞاك٤ش  .51     
 ػٔبٍ الأعجغذ .61     
 ػٔبٍ اُغِٞد  .71     
 اُج٘بءػٔبٍ  .81     
 ػٔبٍ اُز٘ظ٤لبد .91     
 سثخ اُج٤ذ .02     
 أخشٟ .12     
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 اٌمؽُ اٌضبٌش : اٌؽىٓ
 
 ؼٕٛاد) 3أٚز أْ أؼأٌه حٛي ؼىٕه اٌحبٌٟ ٚاٌؽبثك  (لا رفًّ الإلبِخ فٟ ؼىٓ ٌّسح رمً ػٓ 
 
 ) ِب ٔٛع اٌؽىٓ اٌصٞ ػفذ ف١ٗ؟   32غ 
 
 ***ٓج٘٠
 ػبئلاد) 01. ٓج٘٠ عٌ٘٢ (أًضش ٖٓ 3ػبئلاد)        01عٌ٘٢ ( اهَ ٖٓ ٓج٘٠ . 2. ٓ٘ضٍ خبص        1  :ٔٛع إٌّعي 
 .أخشٟ6  خ.عٌٖ ك٢ ٓضسػ5 . خ٤ٔخ4    
 ؽبثن أػِ٠ .4  . ؽبثن صبُش    3 . ؽبثن صبٗ٢  2  ؽبثن أسػ٢   1  اٌطبثك : 
 .أخشٟ5 
 لا أػشف .5 ٓ٤بٙ ٓؼذٗ٤خ    .4 طٜبس٣ظ    .3 ثئش    .2 .أٗبث٤ت1 :ِمسض اٌّبء 
 أخشٟ .6 
 .أخشٟ3 ك٢ اُخبسط .2 ك٢ اُذاخَ .1 اٌحّبَ : 
اٌفزطح 
 اٌعِٕ١خ
 
ِىبْ 
 اٌحّبَ
 
ػسز 
 اٌغطف
ػسز الأـربق 
اٌّم١ّ١ٓ فٟ 
 إٌّعي
ِمسض 
ِبء 
 اٌفطة
اٌطبثك 
اٌصٞ 
 رؼ١ؿ ف١ٗ
 ٔٛع
  يإٌّع
 رمٕ١ف
 اٌّىبْ
 اٌؼٕٛاْ
    
 :اٌحبٌٟ    
 اُشبسع:_______________
 أُذ٣٘خ (اُجِذح): __________
    
 :اٌؽبثك    
 اُشبسع:_____________ .1
 أُذ٣٘خ (اُجِذح): __________
    
 اُشبسع:_____________ .2    
 أُذ٣٘خ (اُجِذح): __________
   
 اُشبسع:_____________ .3     
 أُذ٣٘خ (اُجِذح): __________
   
 اُشبسع:_____________ .4     
 أُذ٣٘خ (اُجِذح): __________
   
 اُشبسع:_____________ .5     
 أُذ٣٘خ (اُجِذح): __________
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 اٌؼبزاد اٌمؽُ اٌطاثغ :
 
 
ظبئظي اُشخظ٤خ ًو٤بعبري اُغغٔ٤خ ، ٝثؼغ ػبداري ًبُزذخ٤ٖ ، رض٣٤ٖ اُشؼش، غ خأٝد إٔ أعأُي حٍٞ ثؼ
 :اُزؼشع ُِشٔظ ، ٝاُحٔ٤خ اُـزائ٤خ ٝ أخشٟ
 
 
 اٌغؽّ١خ؟بره ) ِب ٟ٘ ل١بؼ 42غ 
 
 
 
 
  
 ٗلظ اُش٢ء  . 1 ***
 أػِ٠ ثٌض٤ش    .2 
 %)01 حز٠(ثوِ٤َأػِ٠  . 3 
 أهَ ثٌض٤ش   .4 
 %)01حز٠(ثوِ٤َأهَ  . 5 
 
 
 ؟ )13)  ً٘ ؼجك ٌه أْ زذٕذ ( ئشا ٌُ رسذٓ أثسا ، اش٘ت ئٌٝ غ 52غ 
 
  .  اُغغبئش 1
  . اُ٘شع٤ِخ2
  .اُـِ٤ٕٞ3
  . اُزجؾ 4
  . ُْ أدخٖ أثذا5
 
 
 ) ً٘ أٔذ ِسذٓ حبٌ١ب؟ 62غ 
 
 . لا    2.ٗؼْ                       1
 
 ) ً٘  ألٍؼذ ػٓ اٌزسذ١ٓ؟ 72غ 
 
 . لا    2   .ٗؼْ  1
 
 
 ) وُ ؼٕخ زذٕذ ؟ 82غ
 
 
 
 فٟ اٌ١َٛ ؟) وُ ػسز اٌؽغبئط اٌزٟ رسذٕٙب (زذٕزٙب )  92غ 
 
 
 
 
 ع٤غبسح  04أًضش ٖٓ: 4       04-12: 3     02-11: 2أهَ           ٝأ عغبئش   01:1
  
 اٌّإـطاد اٌم١بغ ػٕس اٌّطن  اـٙط لجً اٌّطن 6اٌم١بغ 
 اُطٍٞ    
 اُٞصٕ  
 
 اٌفزطح اٌعِٕ١خ ػسز اٌؽغبئط
 ٓؼذٍ اُزذخ٤ٖ هجَ أُشع 
 أُغزٟٞ اُحبُ٢ ُِزذخ٤ٖ 
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 )      ِب ٘ٛ ِؼسي رسذ١ٕه (ٌٍٕطع١ٍخ أٚ اٌغٍ١ْٛ أٚ اٌزجغ )، لجً اٌّطن ٚ حبٌ١ب ؟ 03غ 
 
 
 
 
 
 : أهَ ٖٓ ٓشح ك٢ الأعجٞع 3عجٞع    : أًضش ٖٓ ٓشح ك٢ الأ 2ًَ ٣ّٞ      .1***
 
 
 ) 73غ  اش٘جاٌٝ" لا " ،  الإعبثخ) ً٘ ؼجك ٌه أْ لجغذ ـؼطن؟؟   ( ئشا وبٔذ 13غ 
 
 . لا2  .ٗؼْ     1
 
 ؟  ثبٔزظبَ) ً٘ رمجغ١ٓ ( رمجغ)  ـؼطن 23غ 
 
 . لا    2   .ٗؼْ  1
 
) فٟ أٞ ػّط ثسأد ثمجبغخ  33غ  ـؼطن؟
 
 
 ) ثبٌّؼسي ، وُ ِطح رمجغ١ٓ (رمجغ) ـؼطن؟43غ 
 
ٓشاد ك٢  7. أًضش ٖٓ 4  ع٘خ/ٓشاد 6-4. 3  ع٘خ/ٓشاد 3-1. 2  ع٘خ/أهَ ٖٓ ٓشح.1
 اُغ٘خ 
 
 ٌْٛ رؽزرسِ١ٓ ( رؽزرسَ) فٟ اٌؼبزح؟) أٞ 53غ 
 
 .أُٞإ أخشٟ 5  .ُٕٞ اُح٘بء  4 .الأشوش 3  . اُج٘٢2 الأعٞد .1
 
 )ً٘ اٌمجغخ اٌزٟ رؽزرسِٙب الطٕبػ١خ؟63غ 
 
 . لا   2.ٗؼْ                  1
 
 ) ً٘ رؼطوذ ٌلإلبثخ ثحطٚق ـّػ حبزح  فٟ يفٌٛزه؟73غ 
 
 أرًش .لا3. لا         2.ٗؼْ                1
 
 
) وُ ؼبػخ فٟ الأؼجٛع رزؼطن ( رؼطوذ) ٌىٛء اٌفّػ فٟ اٌربضط،  ذبضط ؼبػبد ػٍّه (اـًّ 83غ 
 رؼطوه ذلاي أٚلبد فطاغه ٚش٘بثه ٚضعٛػه ِٓ اٌؼًّ )
 
 
 
 
 ) ػٕسِب رىْٛ فٟ اٌربضط ، ً٘ ٠ىْٛ  ضأؼه ِغطٝ ؟ 93غ 
 
 . أثذا4 . أح٤بٗب 3 .ٓؼظْ اُٞهذ 2 دائٔب  .1
  
 اٌفزطح اٌعِٕ١خ إٌطع١ٍخ اٌغٍ١ْٛ اٌزجغ
 ٓؼذٍ اُزذخ٤ٖ هجَ أُشع   
 أُغزٟٞ اُحبُ٢ ُِزذخ٤ٖ   
 
 
   29 
 
 رىْٛ فٟ اٌربضط ، ً٘ رٍجػ أوّبَ يٛ٠ٍخ ؟)  ػٕسِب 04غ 
 
 . أثذا4 . أح٤بٗب 3  .ٓؼظْ اُٞهذ2  دائٔب  .1
 
 
 ) ً٘ رؽزرسَ ٚالٟ ـّػ ػٕسِب ررطط فٟ اٌفّػ؟14غ 
 
 . أثذا4 . أح٤بٗب 3  .ٓؼظْ اُٞهذ 2  دائٔب  .1
 
 
 ) ً٘ رٍم١ذ ضوبػخ يج١ؼ١خ؟  24غ 
 
 . لا أدس١     3. لا                         2.ٗؼْ                       1
 
 
  ) 54ٔٛع ِٓ اٌٍحَٛ)؟ (ئشا وبٔذ الإعبثخ لا ، اش٘ت ئٌٝ غ  رأولأٞ) ً٘ أٔذ ٔجبرٟ (لا  34غ 
 
 . لا    2                  .ٗؼْ     1
 
 
 ) وُ ؼٕخ وٕذ ٔجبرٟ؟ 44غ 
 
 
 )74(ئشا وبٔذ الإعبثخ لا , أزمً ئٌٝ ؼإاي  ٚ ث١ىبء)أ(ٌحَٛ حّطاء ؟ اٌٍحَٛ ثبٔزظبَ)  ً٘ رزٕبٚي  54غ 
 
 . لا       2.ٗؼْ                    1
 
 
) وُ ِطح فٟ الأؼجٛع رأوً 64غ  اٌٍحَٛ؟
 
 
 ) ِب ٘ٛ ِؼسي حجبد اٌفبوٙخ اٌزٟ رزٕبٌٚٙب ٠ِٛ١ب؟74غ 
 
  7)  أًضش ٖٓ  4            7-4 )3           3-1) 2ٝلا ٓشح        )1
 
 
 ) ِب ٘ٛ ِؼسي حجبد اٌرىبض اٌزٟ رزٕبٌٚٙب ٠ِٛ١ب؟84غ 
 
  7)  أًضش ٖٓ  4              7-4 )3           3-1) 2ٝلا ٓشح        )1
 
 
 فٟ اٌطٟٙ ٚاٌمٍٟ ثفىً أؼبؼٟ؟رؽزرسِ١ٕٙب   /) أٞ ٔٛع ِٓ اٌع٠ٛد رؽزرسِٗ94غ 
 
 ___) أخشٟ_________ 5) ػجبد اُشٔظ  4) اُزسح      3  ٣ب) اُظٞ 2اُض٣زٕٞ     )1
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 :) ػبزح وُ ِطح رأوً أٚ رفطة الألٕبف اٌزبٌ١خ05غ 
 
 
 
 اٌمؽُ اٌربِػ : اٌٙٛا٠بد
 
 .أٚز أْ أؼأٌه حٛي ٘ٛا٠بره وبٌغٙس اٌجسٟٔ اٌصٞ رّبضؼٗ ، اٌفْٕٛ ، ٚأذطٜ
 
 اش٘جاٌٝ" لا " ،  الإعبثخ) أصٕبء اٌؽٕٛاد اٌؼفط الأذ١طح ، ً٘ ِبضؼذ أٞ عٙس ثسٟٔ ِٕزظُ ؟ ( ئشا وبٔذ 15غ 
 ) 55غ 
 . لا   2.ٗؼْ                       1
 
 ) ِب ٘ٛ ٔٛع اٌغٙس اٌصٞ ِبضؼزٗ؟25غ 
 
    شبم (ًبُشًغ) .1
        ٓزٞعؾ ( ًبُٔش٢) .2
    خل٤ق( ًبُجغز٘خ)  .3
  
 الأح١بْ، وُ ِطح ِبضؼذ اٌغٙس اٌجسٟٔ؟ ) فٟ أغٍت35غ 
 
   صلاس ٓشاد ك٢ الأعجٞع أٝ أًضش .1
    ٓشر٤ٖ ك٢ الأعجٞع .2
    ٓشح ٝاحذح أعجٞػ٤ب .3
     أهَ ٖٓ رُي .4
  1 2 3 4 5 6 7 8
 اٌ١َٛاٌىّ١خ فٟ  
 
أوضط ِٓ ِطح 
ٚاحسح فٟ 
 وً ٠َٛ
ِطح ٚاحسح 
فٟ وً 
 ٠َٛ
فٟ  أ٠بَ 6-5
 الأؼجٛع
فٟ  أ٠بَ 4-2
 الأؼجٛع
ِطح فٟ 
 الأؼجٛع
ألً ِٓ ِطح 
فٟ 
 الأؼجٛع
 ٚلا
 ِطح
 
        ___
 فٛاوٗ-1
        ___
 ُذىطاٚاد -2
        
 ٌحَٛ أٚ زعبط-3
        
 ؼّه-4
        
حٍ١ت وبًِ / لٍ١ً -5
 اٌسؼُ
        
ِٕزغبد اٌحٍ١ت -6
 أٚاٌغجٕأٚ(ِضً اٌٍجٓ 
 اٌفىٛلارخ ثبٌحٍ١ت)
        أوٛاة___
 ـطة اٌّبء فمً-7
        أوٛاة___
ِفطٚثبد أذطٜ -8
غ١ط وحٌٛ١خ (ؼبذٕخ 
 ٚثبضزح)
        أوٛاة___
 ِفطٚثبد وحٌٛ١خ-9
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 ، ٚوُ ِطح ػبزح؟ ا٢ر١خ) ً٘ ِبضؼذ أٞ ِٓ إٌفبيبد اٌجسٔ١خ 45غ 
 
 
 ) 46غ  اش٘جاٌٝ" لا " ،  الإعبثخ) ً٘ رؼزٕٟ ثبٌحس٠مخ وٙٛا٠خ؟ ( ئشا وبٔذ 55غ 
 
 . لا       2.ٗؼْ                       1
  
 ) أٞ ٔٛع ِٓ اٌجؽزٕخ رإزٞ؟ 65غ 
 
 ك٢ اُخبسط. 2  ك٢ اُذاخَ .1
  
 
 
  ) وُ ؼٕخ ِبضؼذ اٌجؽزٕخ ؟ 75غ 
  
  ) وُ ؼبػخ فٟ الأؼجٛع ِبضؼذ اٌجؽزٕخ ؟ 85غ 
 
  عبػبد ك٢ الأعجٞع 01أهَ ٖٓ  .1
   عبػخ ك٢ الأعجٞع 02-01 .2
       عبػخ ك٢ الأعجٞع 02أًضش ٖٓ  .3
لا ألَٛ ثٙصا .1 إٌفبيبد اٌجسٔ١خ #
 إٌفبي
صلاس  -ِطر١ٓ  .2
 ِطاد ثبٌفٙط
ِطر١ٓ ثبلأؼجٛع .4 ِطح ثبلأؼجٛع.3
 أٚ أوضط
     وطح لسَ ،  ٠س ، رٕػ ، ؼٍخ، اٌٙٛوٟ ، أٌؼبة وطح أذطٜ 1
     أٌؼبة ض٠بو١خ ( أٌؼبة لٜٛ ) ، عّجبظ   2
رّبض٠ٓ ٌ١بلخ ثسٔ١خ، اـزطان فٟ ٔبزٞ ٌ١بلخ ثسٔ١خ ، عٙبظ  3
 ضوه ث١زٟ
    
     اٌّفٟ اٌؽط٠غ ٚاٌطوه 4
     اٌىبضار١ٗ ، عٛزٚ ، رب٠ىٛٔسٚ 5
     اٌّمبضػخ 6
     اٌّلاوّخ 7
     الأصمبيضفغ  8
     اٌطلك ٚاٌسثىخ 9
     اٌىفبفخ 01
     اٌؽجبحخ 11
     ضوٛة اٌسضاعبد اٌٙٛائ١خ 21
     رؽٍك اٌغجبي 31
     اٌزعٌظ ٚاٌزعحٍك 41
     اٌّفٟ اٌطٛ٠ً ٚل١س الأؼّبن 51
اٌّبئ١خ (الإثحبض ، ضوٛة الأِٛاط ، ٚاٌزعحٍك   الأٔفطخ 61
 ػٍٝ اٌّبء)
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 ٚاٌفٛاوٗ ؟) ً٘ رعضع (ظضػذ)  اٌرىبض 95غ 
 
    ُي شخظ٤ب   .1
     ُِج٤غ .2
   ٚلا أصسع اُخؼبس ٝاُلٞاً .3
 
 
 ) 46غ اش٘جاٌٝ" لا " ،  الإعبثخ) ً٘ رؽزؼًّ أٚ (اؼزؼٍّذ) اٌّج١ساد اٌحفط٠خ ؟ ( ئشا وبٔذ 06غ 
 
 .لا أػشف3       . لا2.ٗؼْ                       1
 
 اٌّج١ساد اٌحفط٠خ؟ ) لفبظاد ٚلبئ١خ ػٕسِب رؽزرسَاضرس٠ذ) ً٘ رطرسٞ (16غ 
 
 . أح٤بٗب  3   .ك٢ ٓؼظْ الأٝهبد2  ك٢ عٔ٤غ الأٝهبد.1 
 .أثذا 4    
 
 
 ) ً٘ رغؽً (غؽٍذ ) ٠س٠ه ثؼس اؼزرساَ اٌّج١ساد؟26غ 
 
 . أح٤بٗب  3   .ك٢ ٓؼظْ الأٝهبد2  ك٢ عٔ٤غ الأٝهبد.1 
 .أثذا 4    
 
 ) اٌّج١ساد اٌحفط٠خ اٌزٟ رؽزرسِٙب أٚ اؼزرسِزٙبٟ٘ وس : 36غ 
 
 .لا أػشف 4. اُلطش٣بد         3. اُحششاد       2          الأػشبة.1
 
 
 ) ً٘ رطؾ (ضـ١ذ) ِج١ساد حفط٠خ زاذً ِٕعٌه؟46غ 
 
     ك٢ الأعجٞع   أًضشٓشح أٝ  .1
  ٓشح ك٢ اُشٜش   –. أهَ  ٖٓ ٓشح ك٢ الأعجٞع  .2
    د ك٢ اُغ٘خ ثؼغ أُشا  .3
      أثذ  .4
 
 
؟ ( ئشا وبٔذ الإعبثخ " لا  )ِٕعٌهك٢أٚاٌجؽزٕخك٢) ً٘ رصوط اؼُ اٌّج١س (اٌّج١ساد) اٌحفط٠خ(اٌزٟ اؼزرسِزٙب56غ 
 ) 76غ  ئٌٝ" ، ئش٘ت 
 
 . لا       2.ٗؼْ                       1
 
 
 اؼزؼٍّزٙب؟) ِب ٘ٛ اؼُ ( أؼّبء) اٌّج١س (اٌّج١ساد) اٌحفط٠خ اٌزٟ 66غ 
 
 
 
 
 
 
 
 
 اعْ أُج٤ذ
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)ػٕسِب وٕذ ضو١غ أٚ يفً لغ١ط ،ً٘ وٕذ رص٘ت ئٌٝ اٌحمً اٌعضاػٟ ِغ ٚاٌس٠ه أٚ أـمبءن الأوجط ِٕه 76غ 
 ؼٕب ؟ 
  . لا أرًش  3. لا       2.ٗؼْ                       1
 
 ) 57" لا " ، اش٘ت ئٌٝ  الإعبثخاٌ١سٚ٠خ (وبٔذ) ِٚب ظاٌذ ِٓ أحس ٘ٛا٠بره؟ ( ئشا وبٔذ  الأـغبي) ً٘ 86غ 
 . لا أرًش  3  . لا      2.ٗؼْ                       1
 
 ِبضؼذ (أٚ رّبضغ حبٌ١ب)؟  الأـغبي) أٞ ٔٛع ِٓ 96غ 
    اُزِٞ٣ٖ  .1
    اُ٘حذ  .2
   اُلخبس٣بد ٝاُغ٤شآ٤ي  .3
    اُُضَعبِع٤ّبد  .4
  اُطجبػخ ٝاُطجبػخ ػِ٠ اُحغش  .5
   اُؼَٔ اُحذ٣ذ١  .6
 كٖ رشٌ٤ِ٢ .7
 __________________________   ؿ٤شٛب .8
 
 ) ذلاي ِّبضؼزه ٌلأـغبي اٌ١سٚ٠خ ، ً٘ رؼطوذ ( رزؼطن ) ٌٍّٛاز اٌى١ّبٚ٠خ اٌزبٌ١خ:07غ 
     .أُٞإ ص٣ز٤خ1
    . أؽِ٤خ عبئِخ ( أًش٣ِ٤خ)2
     .دٛبٗبد أخشٟ3
   ( اُزشث٘ز٤ٖ ، اٌُبص. ٓز٣جبد ( 4
     . الأطٔبؽ5
      . اُـجبس6
     . اُشطبص7
 __________________________   . ؿ٤شٛب8
 
  
  اٌ١سٚ٠خ ؟  الأـغبي) وُ ػسز اٌؽٕٛاد اٌزٟ ِبضؼذ ف١ُٙ 17غ 
  
 
  اٌ١سٚ٠خ ؟  الأـغبي) وُ وبْ ػّطن ػٕسِب ثسأد ثّّبضؼخ 27غ 
 
 
  اٌ١سٚ٠خ ؟  الأـغبي) وُ وبْ ػّطن ػٕسِب رٛلفذ ػٓ ِّبضؼخ 37غ 
 
  اٌ١سٚ٠خ ؟  الأـغبي) وُ ؼبػخ فٟ الأؼجٛع رّبضغ(ِبضؼذ)  47غ 
عبػخ ك٢  02أًضش ٖٓ  .3 عبػخ ك٢ الأعجٞع 02-01 .2  عبػبد ك٢ الأعجٞع 01 أهَ ٖٓ.1
 الأعجٞع
        
" لا " ، اش٘ت  الإعبثخ) ً٘ ػٕسن ٘ٛا٠بد أذطٜ ٚاٌزٟ رزىّٓ اؼزرساَ اٌى١ّبٚ٠بد؟ ( ئشا وبٔذ 57غ  
  )81ئٌٝ غ 
 . لا      2.ٗؼْ                       1
 
   ) ِب ٟ٘ اٌٙٛا٠خ؟67غ 
 
 
   )  ِب ٘ٛ ٔٛع اٌّبزح اٌى١ّ١بئ١خ اٌّؽزرسِخ  فٟ ٘صٖ اٌٙٛا٠خ؟77غ 
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   ػٕسِب ِبضؼذ ٘صٖ اٌٙٛا٠خ؟)  وُ وبْ ػّطن 87غ 
  
  ) وُ ؼبػخ فٟ الأؼجٛع رّبضغ(ِبضؼذ) ٘صٖ اٌٙٛا٠خ؟ 97غ 
عبػخ ك٢  02أًضش ٖٓ  .3 عبػخ ك٢ الأعجٞع 02-01 .2  عبػبد ك٢ الأعجٞع 01 أهَ ٖٓ.1
 الأعجٞع
 
 
 
 
 
 
 اٌمحخ اٌمؽُ اٌؽبزغ :
 
 هجَ أُشع، أس٣ذ إٔ أعأُي حٍٞ حبُزي اُظح٤خ  ا٥ٕ
 
" لا " ، اش٘ت ئٌٝ  الإعبثخزاَ لأوضط ِٓ ٠ِٛ١ٓ؟( ئشا وبٔذ  ئؼٙبي،ً٘ ؼجك ٌه أْ ػبٔ١ذ ِٓ اٌّطنلجً ) 08غ 
  ) 28غ 
 
 .لا أرًش3    . لا    2.ٗؼْ                       1
 
اٌحبز ٔز١غخ  الإؼٙبيً٘ وبْ ٘صا ئؼٙبي ذلاي اٌؽٕٛاد اٌؼفط الأذ١طح لجً اٌّطن ٚ  ػبٔ١ذ ِٓوُ ِطح  )18غ 
  : ا٢ر١خججبد أحس اٌّؽ
 
 اٌّؽجت ػسز اٌّطاد ِزٝ وبٔذ أذط ػسٜٚ
 (اُغبُٔٞٗ٤لا) allenomlaS . 1   
 (ش٤ ِـ ٤لاا ) allegihS . 2   
 (اٌُبٓج٤ِٞثٌزش)  retcabolypmaC . 3   
 (اُ٤َْشَع٘٤ِا٤ب)            ainisreY . 4   
 ((الأُْعطٞٗ٤ِابد sisodiolignortS .5   
 .الأٓ٤جب                            6   
 . ػذٟٝ ؽل٤ِ٤خ أخشٟ                                    7   
 (ا١ ًٞلا١) iloc.E .8    
 أػِٔذ ثإٔ أُغجت كب٣شٝط.9   
 . ُْ ٣غذٝا أُغجت 01   
 . ُْ ٣زْ اُلحض11   
 .أخشٟ21   
 
 
  ِٓ ػّطن؟ الأٌٚٝ ) ً٘ ػبٔ١ذ ِٓ أٞ ِطن ٚ اٌصٞ رطٍت اٌؼلاط فٟ اٌّؽزففٝ ذلاي اٌؽٕخ 28غ 
 
 . لا أػشف 3. لا            2.ٗؼْ                       1  
 
   ّطن؟________________________ِب ٘ٛ ٘صا اٌ
 
 اش٘جاٌٝ" لا " ،  الإعبثخحبز  ٚاٌصٞ رطٍت اٌؼلاط فٟ اٌّؽزففٝ ؟ ( ئشا وبٔذ  اٌزٙبة) ً٘ ػبٔ١ذ ِٓ أٞ 38غ 
  ) 58غ 
 
 . لا أرًش   3. لا            2.ٗؼْ                       1
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  ٚفٟ أٞ ػّط؟  الاٌزٙبة) ِب ٘ٛ ٘صا الاٌزٙبة، ٚوُ ِطح زذٍذ اٌّؽزففٝ ٔز١غخ  48غ 
 
 
 
 
 
 
 
 
 ضِٛظ اٌؼسٜٚ :***
 ػذٟٝ أُشاسح .4  ٓؼٞ١ اُزٜبة.3 اُشؼت اُٜٞائ٤خ اُزٜبة.2  بُغ٤ٞةاُزٜبث.1
 اُغِذ  اُزٜبة.8 اُؼذٟٝ اُششع٤خ    .7 اُجشٝعزبد   اُزٜبة.6 ػذٟٝ أُغبُي اُجُٞ٤خ   .5
 اُزٜبة اُضائذحُذٝد٣خ .11 اُزٜبة اُغحب٣ب     .01  ػذٟٝ ك٢ اُغٜبص اُز٘بعِ٢ الأٗضٞ١ (ُِ٘غبء كوؾ) .9
 أخشٟ.21
 
اٌزٟ رطٍجذ اٌؼلاط فٟ اٌّؽزفف١بد ، ً٘ ػبٔ١ذ ِٓ أٞ ِٓ الأِطان الأر١خ ؟  الاٌزٙبثبد) ثغه إٌظط ػٓ 58غ 
  اٌؼسٜٚ اٌّٛعٛز رحذ اٌغسٚي ٌزحس٠س اٌؼّط)ضِع ظِٓ  ئشا وبْ اٌغٛاة ٔؼُ،  ِزٝ؟ (اؼزرسَ 
 
 اٌغ١ً:ضِع ***
 أهَ ٖٓ ع٘خ.5ع٘ٞاد          01-1 .4ع٘خ        02-11.3ع٘خ        04 – 12.2ع٘خ 04أًضش ٖٓ  .1
 
 اٌؼّط ػسز اٌّطاد ٔٛع اٌؼسٜٚ
 ع٘خ 04ٖٓ أًضش  .1  
  ع٘خ 04 – 12. 2  
 ع٘خ 02-11. 3  
 ع٘ٞاد  01-1. 4  
 . أهَ ٖٓ ع٘خ5  
 اٌّطن ٔؼُ      لا     لا أشوط اٌؼّط
 A.اُزٜبة اٌُجذ 1    
  B.اُزٜبة اٌُجذ2    
 C.اُزٜبة اٌُجذ 3    
 ، الأرٕ ، أخشٟ الأٗق(اُوٞثبء): اُشلز٤ٖ، sepreH .4    
  sisoelcunonoM suoitcefnI .5    
 (حٔ٠ )  suriV raB nietspE
 (اُشثٞ) amhtsA .6    
 ( الأًض٣ٔب) amezcE .7    
 (إُزٜبة اُِٞصر٤ٖ) sitillisnoT .8    
 ( اُحظجخ) selsaeM .9    
 (اٌُ٘بف) spmuM .01    
 (اُحظجخ الأُٔبٗ٤خ) allebuR .11    
  revef citamuehR. حٔ٠ اُشُّ ٝٓبرضّ 21    
  sitirhtra diotamuehR . اُزٜبة أُلبطَ31    
 . اُغَ41    
 (اُحٔ٠ أُبُط٤خ) sisollecurB .51    
 اُغ٤ٞة اُزٜبة.61    
 ٓؼٞ١ اُزٜبة.71    
 .شَِ الأؽلبٍ81    
 . اُز٤لٞط91    
 .اُوشحخ02    
 .اُحغبع٤خ12    
 .الاُزٜبثبد أُؼٞ٣خ (ٓضَ حغبع٤خ اُؤح اٝ اُغِٞر٤ٖ)22    
 .اُظذك٤خ32    
 . الأٓشاع أُ٘بػ٤خ اُزار٤خ42    
 الأخشٟ. الأٓشاع أُ٘بػ٤خ 52    
 .أٓشاع أخشٟ62    
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 ) ً٘ رٍم١ذ اٌزطؼ١ّبد وس الأِطان اٌزبٌ١خ؟68غ 
 
 
  ) 98غ  اش٘جاٌٝ" لا " ،  الإعبثخ)ً٘ ذىؼذ  لاؼزئمبي اٌٍٛظر١ٓ؟  ( ئشا وبٔذ  78غ 
 
 . لا       2.ٗؼْ                       1
  
 
   )  وُ وبْ ػّطن ؟88غ 
 
 
  ) 19" لا " ، اش٘ت ئٌٝ غ  الإعبثخ) ً٘ ؼجك ٌه أْ رؼبي١ذ ِىبزاد ح١ٛ٠خ ؟ ( ئشا وبٔذ 98غ 
 
 . لا    2.ٗؼْ                       1
 
 
  ) ثبٌّؼسي ،  وُ ِطح فٟ اٌؽٕخ رٕبٌٚذ اٌّىبزاد اٌح١ٛ٠خ ، ٚفٟ أٞ ؼٓ؟09غ 
 
 
 
 
 
 
 
ػٕس  اذط اٌؼّط 
 رطؼ١ُ
اٌؼّط ػٕس 
 اٌزطؼ١ُ الأٚي
 اٌّطن ٔؼُ لا لا أشوط
 .داء اٌُضاص1     
 .اُغذس١2     
 .اُز٤لٞئ٤ذ3     
 .اُحظجخ4     
 .اٌُ٘بف5     
 .اُحظجخ الأُٔبٗ٤خ6     
 .اُغؼبٍ اُذ٣ٌ٢7     
 )رطؼ٤ْ ثبُحوٖ. شَِ الأؽلبٍ ( 8     
 عبئَ ثبُلْ).شَِ الأؽلبٍ (رطؼ٤ْ 9     
 . اُغَ01     
 . اُحٔ٠ اُظلشاء11     
 . اُزٜبة اُغحب٣ب اُل٤شٝع٢21     
 . اٌُُٞ٤شا31     
 اٌُجذ اُحبد (أ) اُزٜبة.41     
 اٌُجذ (ة) اُزٜبة. 51     
 . ثٌز٤ش٣ب اُٜ٤ٔٞك٤ِظ61     
.ٗ٤ًًٞٓٞٞظ (اُجٌز٤ش٣ب أٌُٞسح 71     
 اُذٝس٣خ)
 الاٗلِٞٗضا.كب٣شٝط 81     
 .اُخ٘بم91     
 .أخشٟ02     
 اٌؼّط   ِؼسي ػسز اٌّطاد  فٟ اٌؽٕخ   
 ع٘خ 04.أًضش ٖٓ 1 
  ع٘خ 04 – 12. 2 
 ع٘خ 02-11. 3 
 ع٘ٞاد  01-1. 4 
 ع٘خ. أهَ ٖٓ 5 
   001 
 
  ) ً٘ ؼجك ٌه أْ رؼطوذ ٌلأـؼخ لجً ِطوه  ؟19غ 
 
 .لا أرًش3. لا              2.ٗؼْ                       1
 
 
  ) ٌّبشا لّذ ثؼًّ الأـؼخ؟29غ  
 
 
 
 
 
 
 
 
 اٌغ١ً:ضِع ***
ع٘ٞاد            01-1 .4ع٘خ        02-11.3ع٘خ        04 – 12.2ع٘خ 04ًضش ٖٓ . أ1
 أهَ ٖٓ ع٘خ.5
 
 
  ؟ 81)  أٞ ِٓ اٌغًّ اٌزبٌ١خ رمف يفٌٛزه حزٝ ؼٓ 39غ 
 
   أطذهبئ٢ك٢ أؿِت الأح٤بٕ أًضش ٖٓ  أٓشع. ً٘ذ 1
  ػٖ أُذسعخ أًضش ٖٓ أطذهبئ٢  رـ٤جذ 2
ً٘ذ ؽللا . 4  . حظِذ ػِ٠ أدٝ٣خ أًضش ٖٓ أخٞر٢ ٝأخٞار٢ 3
  ثظحخ ع٤ذح ك٤ٔب ػذا رؼشػ٢ لأٓشاع اُطلُٞخ اُؼبد٣خ
   . ً٘ذ أٓشع ٌُٖٝ أهَ ثٌض٤ش ٖٓ أطذهبئ٢ ٝأشوبئ٢5
   
     
" لا "،  الإعبثخ)ً٘ ٌس٠ه ح١ٛأبد أٌ١فخ أٚ ح١ٛأبد وج١طح فٟ ِٕعٌه أٚ فٟ حسائك ِٕعٌه ؟ (ئشا وبٔذ 49غ 
 ) 69غ اش٘جاٌٝ
 
 . لا       2.ٗؼْ                       1
 
 
  ) ِب ٔٛع اٌح١ٛأبد ػٕسن (وبْ ػٕسن)؟59غ 
  
  . هؾ 1
  . ًِت  2
  . ؽ٤ٞس  3
  . حظبٕ   4
  . ثوشح   5
  . عَٔ   6
  . ٓبػض  7
  . أؿ٘بّ  8
  . حٔبس    9
  أخشٟ. 01
 
 
 
 Xأشؼخ  ػذد أُشاد اُغ٘خ
 .أشؼخ أع٘بٕ1  
 .أشؼخ طذس2  
 .رظٞ٣ش اُضذ١ (ُِ٘غبء)3  
 .أشؼخ ػظبّ4  
 .أخشٟ5  
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ٔؼُ، فٟ أٞ ػّط ، ٚوُ  الإعبثخثٛلفخ يج١خ ؟ ئشا وبٔذ  ا٢ر١خ) ً٘ ؼجك ٌه أْ رٕبٌٚذ أٞ ِٓ الأزٚ٠خ 69غ 
 ِطح؟
 
 
  ) ً٘ ؼجك ٚأْ ٔمً ئٌ١ه زَ لجً ِطوه؟ 79غ  
 
 . لا أػشف 3. لا        2.ٗؼْ                       1
 
 
  ) 001غ اش٘جاٌٝ" لا " ،  الإعبثخ) لجً ِطوه اٌحبٌٟ ، ً٘ ؼجك ٌه أْ ألجذ ثبٌؽطيبْ؟  ( ئشا وبٔذ 89غ 
 
 . لا       2.ٗؼْ                       1
 
 
 اٌؼلاط اٌصٞ رٍم١زٗ؟) ِب ٘ٛ 99غ 
 
  اُؼلاط اٌُ٤ٔبٝ١. 1
   . اُغشاحخ2
  . اُؼلاط ثبلأشؼخ 3
   . لا أػشف4
  
 
  
 الأزٚ٠خ أثسا أح١بٔب  ثفىً ِٕزظُ
ؼٕخ 
 الأزٙبء
ؼٕخ 
 اٌجسء
 . اُغزشٝ٣ذاد ( اٌُٞسرضٕٝ ٝ ٓشزوبرٚ)1    
 ٓٞاٗغ اُحَٔ اُٜشٓٞٗ٤خ .2    
 عٖ اُ٤أط (اعزشٝع٤ٖ) ػلاط ثذ٣َ ٛشٓٞٗ٢ ك٢ .3    
 . اُٜشٓٞٗبد الأخشٟ ____________4    
 .ٓؼبد اُلطش٣بد ( كٔٞ١ )5    
(الأدٝ٣خ اُـ٤ش إعز٤شٝد٣خ اُ ُٔؼبدح  sDIASN. 6    
 ُلإُزٜبة)
 . خبكؼبد اُحشاسح7    
 . ٓؼبداد الاًزئبة8    
 .ٓؼبداد اُطل٤ِ٤بد9    
 .ٓؼبداد اُوِن01    
 اُل٤شٝعبد .  ُٓؼبداد11    
 . ٓؼبداد اُٜ٤غزبٓ٤ٖ21    
 .ٓضجطبد ث٤زب31    
 .ٓذسساد اُجٍٞ41    
 .الأدٝ٣خاُخبكؼخ ُؼـؾ اُذّ51    
 (اُجذ٣َ اُذسه٢) tnemecalper dioryhT . 61    
 .أدٝ٣خ رٔ٤٤غ اُذّ71    
 .الأعجش٣ٖ81    
  .اُؼلاط اٌُ٤ٔبٝ١91    
  .أخشٟ ___________________02    
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ِمبة ثبٌؽطيبْ؟ (ئشا وبٔذ الإعبثخ ٔؼُ ، فّٓ ٘ٛ ِٚب اؼّٗ  الأٌٚٝ) ً٘ احس ألطثبئه ِٓ اٌسضعخ 001غ 
 اٌضلاصٟ)
 .لا أػشف   3. لا                       2.ٗؼْ                       1
 
 اٌطفً
 3
 
 اٌطفً
  2 
 اٌطفً
 1
 ٔٛع اٌؽطيبْ الأـمبء الأَ الأة
 .أ١ عشؽبٕ (ٗٞػٚ)1      
 .الأٝساّ اُِ٤ٔلبٝ٣خ اُـ٤ش ٛٞدعٌٖ2      
 amohpmyL s’nikgdoH noN
 .الأٝساّ اُِ٤ٔلبٝ٣خ اُٜٞدعٌٖ3      
 amohpmyL s’nikgdoH
 .  عشؽبٕ اُذّ أُِلبٝ١ أُضٖٓ4      
 aimekuel citycohpmyl cinorhC
 .   عشؽبٕ اُذّ أُِلبٝ١ اُحبد5      
 aimekuel citycohpmyl etucA
 .  اُغشؽبٕ اُ٘خبػ٢ أُزؼذد 6      
 amoleyM elpitluM
 .  عشؽبٕ اُذّ اُحج٤ج٢ اُحبد7      
 aimekueL dioleyM etucA
 .  عشؽبٕ اُذّ اُحج٤ج٢ أُضٖٓ8      
 aimekueL dioleyM cinorhC
 .عشؽبٕ اُذّ9      
 .أٓشاع اُذّ الأخشٟ01      
 
 
 ) ً٘ أحس ألطثبئه ِٓ اٌسضعخ اٌضبٔ١خ ِمبة ثبٌؽطيبْ ؟ (ئشا وبٔذ الإعبثخ ٔؼُ ، فّٓ ٘ٛ)101غ 
 .لا أػشف       3. لا                       2.ٗؼْ                      1
اثٓ الأخ 
 أٚ الأذذ/
أثٕخ الأخ 
 أٚ الأذذ
اثٓ 
أٚاثٕخ 
اٌؼُ 
 أٚاٌربي
اٌؼّخ أٚ 
 اٌربٌخ
اٌؼُ أٚ 
 اٌربي
 
 اٌغسح
ِٓ عٙخ 
 (الأة)
 اٌغسح
ِٓ عٙخ 
 (الأة)
 اٌغس
ِٓ عٙخ 
 )الأَ)
 اٌغسح
ِٓ عٙخ 
 )الأَ)
 ٔٛع اٌؽطيبْ
 .أ١ عشؽبٕ (ٗٞػٚ)1        
 .الأٝساّ اُِ٤ٔلبٝ٣خ اُـ٤ش ٛٞدعٌٖ2        
 amohpmyL s’nikgdoH noN
 .الأٝساّ اُِ٤ٔلبٝ٣خ اُٜٞدعٌٖ3        
 amohpmyL s’nikgdoH
 .  عشؽبٕ اُذّ أُِلبٝ١ أُضٖٓ4        
 aimekuel citycohpmyl cinorhC
 اُحبد.   عشؽبٕ اُذّ أُِلبٝ١ 5        
 aimekuel citycohpmyl etucA
 .  اُغشؽبٕ اُ٘خبػ٢ أُزؼذد 6        
 amoleyM elpitluM
 .  عشؽبٕ اُذّ اُحج٤ج٢ اُحبد7        
 aimekueL dioleyM etucA
 .  عشؽبٕ اُذّ اُحج٤ج٢ أُضٖٓ8        
 aimekueL dioleyM cinorhC
 .عشؽبٕ اُذّ9        
 اُذّ الأخشٟ.أٓشاع 01        
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 ؟ ئشا وبٔذ الإعبثخ ٔؼُ، فّٓ ٘ٛ؟ا٢ر١خ) ً٘ أحس ألطثبئه ِٓ اٌسضعخ الأٌٚٝ وبْ ٠ؼبٟٔ أٞ ِٓ الأِطان 201غ 
 .لا أػشف    3. لا                       2.ٗؼْ                       1
 
 
 ٘ٛ؟؟ ئشا وبٔذ الإعبثخ ٔؼُ، فّٓ ا٢ر١خ) ً٘ أحس ألطثبئه ِٓ اٌسضعخ اٌضبٔ١خ وبْ ٠ؼبٟٔ أٞ ِٓ الأِطان 301غ 
 .لا أػشف    3. لا                       2.ٗؼْ                       1
 
 ) وُ ِطح رص٘ت ئٌٝ يج١ت الأؼٕبْ؟401غ 
  اُغ٘خ).ُِلحٞطبد أُ٘زظٔخ (ٓشح أٝ أًضش ك٢ 1
  ٓشح ًَ ع٘خ ) . ُِلحٞطبد أُ٘زظٔخ ( أهَ ٖٓ2
  .كوؾ ػ٘ذٓب ٣ٌٕٞ ػ٘ذ١ ٝعغ أع٘بٕ أٝ ٓشٌِخ أخشٟ3
  . أثذا4
 
 ) ً٘ رّزٍه ؼ١بضح؟501غ 
 . لا                      2.ٗؼْ                       1 
 
 ) و١ف ٚلٍذ ئٌٝ اٌّؽزففٝ اٌ١َٛ؟601غ
. 5      اُ٘وَ اُؼبّ .4     . ربًغ٢ 3       . ع٤بسح خبطخ2     ٓش٤ب ػِ٠ الأهذاّ.1
  أخشٟ
   
 ؟  ٌٍّؽزففٝ أٚ اٌؼ١بزح) ِزٝ ظ٠بضره اٌمبزِخ701غ 
 
 شٌشا عض٣لا ُزؼبٝٗي
 
 ) رم١١ّبد اٌّمبثٍخ801غ 
   ٓؼزٔذ عذا .1
   ٓؼزٔذ إُ٠ حذا ٓب .2
  حذ ٓب إُ٠ؿ٤ش ٓؼزٔذ  .3
 ؿ٤ش  ٓؼزٔذ .4
 اٌطفً
 3
 
 اٌطفً
  2 
 اٌطفً
 1
 الأِطان الأـمبء الأَ الأة
 أُزٌشسح.اُؼذٟٝ 1      
 .اُحغبع٤خ2      
 .إُزٜبة أُلبطَ(اُشٝٓبرضّ)3      
 . الأٓشاع أُ٘بػ٤خ اُزار٤خ4      
  )sesaesiD enummiotuA(
 . الأٓشاع أُ٘بػ٤خ الاخشٟ5      
اثٓ الأخ 
 أٚ الأذذ/
أثٕخ الأخ 
 أٚ الأذذ
اثٓ 
أٚاثٕخ 
اٌؼُ 
 أٚاٌربي
اٌؼّخ 
أٚ 
 اٌربٌخ
اٌؼُ أٚ 
 اٌربي
 
 اٌغسح
ِٓ 
عٙخ 
 (الأة)
 اٌغسح
ِٓ 
عٙخ 
 (الأة)
 اٌغس
ِٓ 
عٙخ 
 )الأَ)
 اٌغسح
ِٓ 
عٙخ 
 )الأَ)
 الاِطان
 .اُؼذٟٝ أُزٌشسح1        
 .اُحغبع٤خ2        
 .إُزٜبة أُلبطَ(اُشٝٓبرضّ)3        
 . الأٓشاع أُ٘بػ٤خ اُزار٤خ4        
  )sesaesiD enummiotuA(
 . الأٓشاع أُ٘بػ٤خ الاخشٟ5        
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 العوامل الغذائية ومخاطرها عمى الإصابة بمرض الورم الميمفاوي غير الهودجكن بين الفمسطينيين 
 مرام محمد شاكر الفتياني / دحدولإعداد: 
 
 د. رانيا أبو سيرإشراف: 
 
 ممخص: 
في النصف الثاني من القرن العشرين ازدادت نسبة الإصابة بمرض الورم الميمفاوي غير  مقدمة:
اليودجكن حول العالم ثم استقرت في التسعينات لتعود إلى الارتفاع فيما بعد. وقد تبين أن العوامل 
يودجكن البيئية وعادات النظام الغذائي تمعب دورًا ىامًا في التسببب بمرض الورم الميمفاوي غير ال
من خلال التأثير عمى نظام المناعة. وقد تبين لنا أنو لا تتوفر معمومات حول الإصابة بمرض 
 الورم الميمفاوي غير اليودجكن في فمسطين.
المشاركة في إنشاء منصة لدراسة مرض الورم الميمفاوي غير اليودجكن "ب" في فمسطين  الأهداف:
الغذائية وخطر الإصابة بيذا المرض بين المرضى  العلاقة بين العوامل دراسةبالإضافة إلى 
 الفمسطينيين المصابين بمرض الورم الميمفاوي غير اليودجكن "ب" والمجموعة الضابطة.
 )yduts lortnoc-esac( دراسة الحالة والمجموعة الضابطة تصميم البحث:
 3102 – 2002بين  المرضية مقارنة بالمجموعة الضابطة حالةالأجريت دراسة  منهج البحث:
حالة  223حالة مصابة بمرض الورم الميمفاوي غير اليودجكن"ب" التي تم تشخيصيا و 303عمى 
ضابطة من غير المصابين بالمرض من الفمسطينيين البالغين. وقد تم اختيار ىؤلاء من ثلاثة 
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ى ىداسا في مستشفيات رئيسية في الضفة الغربية التي لدييا قسم للأورام بالإضافة إلى مستشف
القدس الغربية. وقد أظير التحميل الأولي أن ىناك خمًلا في التوزيع الجغرافي لمحالات والضوابط 
حالة ضابطة من مراكز  11من المنطفة الوسطى. ولإصلاح ىذا الخمل قامت الباحثة باستقطاب 
ة الضابطة بحيث الرعاية الصحية في أريحا، ورام الله والعيزرية. وقد تم اختيار عناصر المجموع
 dehctam ycneuqerf(تتناسب مع عينة المرضى من حيث العمر والجنس والتوزيع الجغرافي 
-ipEو قد قام المشاركون في الدراسة بالإجابة عمى استبانة تعتمد عمى استبانة  ).slortnoc
ظام الدولية، التي تركزعمى الخصائص الديمغرافية والعوامل البيئية ومن ضمنيا الن hpmyL
 راواتوالحميب ومنتجات الألبان والخض الغذائي ومعدل الاستيلاك من المجموعات الغذائية: المحوم
. إضافة إلى ذلك فقد تم جمع عينات من الدم من المشاركين بيدف تحميميا لمكشف عن اكيةوالف
 الإصابات الفيروسية وتحميل الجينات.
نات لدراسة العلاقة بين العوامل الغذائية لقد تم استخدام قاعدة البيا التحميل الإحصائي:
 وخطرالإصابة بمرض الورم الميمفاوي غير اليودجكن"ب". وتم تحميل البيانات باستخدام برنامج
وفحص الارتباط باستخدام الانحدارالموجستي المتعدد  SSPSالحزمة الإحصائية لمعموم الاجتماعية
ساب القيمة المتوسطة لكل مجموعة من المواد المتغيرات. ولتحميل الاستيلاك الغذائي، تم احت
الغذائية من التوزيع العامل مجتمع الدراسة من أجل ايجاد قيمة ممثمة لمجتمع الدراسة بشكل أقرب 
 من المتوسط واستخداميا كقيمة مرجعية في المقارنات بين مجموعة المرضى والمجموعة الضابطة.
 )3.4-8.0 :IC%59 ;8.1=RO(أظيرت الدراسة أن الاستيلاك العالي لكل من المحوم  النتائج:
مرتبط بشكل إيجابي مع خطرالإصابة بمرض الورم )6.2-7.0 :IC%59 ;3.1=RO(والحميب 
 طيرتب راواتأن استيلاك الخضفي ىذه الدراسة وقد تبين أيضًا  ، كماالميمفاوي غير اليودجكن"ب"
   601 
 
). كذلك فقد وجد أن 4-4.0 :IC%59 ;3.1=RO(يذا المرض خطر الإصابة بارتباطًا إيجابيًا ب
 منتجات الألبان ترتبط بعلاقة ذات دلالة إحصائية بارتفاع خطورة الإصابة بيذا المرض
وفي المقابل، بينت الدراسة وجود علاقة عكسية بين استيلاك ). 4-2.1 :IC%59 ;3.2=RO(
 1.2-2.0 :IC%59 ;7.0=RO((اكيةلفوا) 8.0-2.0 :IC%59 ;4.0=RO( الأسماك
 وخطرالإصابة بمرض الورم الميمفاوي غير اليودجكن"ب"  كمواد تحمي من الإصابة بيذا المرض.
تظير نتائج ىذه الدراسة أن الاستيلاك الغذائي يمعب دورًا في الإصابة بمرض الورم  الاستنتاج:
 ضراواتلحميب ومنتجات الألبان والخوا الميمفاوي غير اليودجكن"ب"، وقد يؤثر استيلاك المحوم
جكن، كما قد يمعب استيلاك سمبًا ويؤدي لزيادة خطر الإصابة بمرض الورم الميمفاوي غير اليود
 والأسماك دورًا في الحماية من الإصابة بالمرض.  اكيةالف
العوامل الغذائية، مرض الورم الميمفاوي غير اليودجكن"ب"، دراسة الحالة  الكممات المفتاحية:
 والمجموعة الضابطة، فمسطين.
 
 
